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Abstract
Biomolecular motor based transport reconstituted in synthetic environment
has been recently established as a promising component for the development
of nanoscale devices. A minimal system consisting of microtubules propelled
over a surface of immobilized kinesin motor proteins has been used to transport
and manipulate cargo for molecular sorting, analyte detection, and other novel
nanotechnological applications. Despite these achievements, further progress
of the field and translation of the reported applications to a real-world setting
require overcoming several key challenges, such as, development of effective cargo
conjugation strategies and precise control of the transport directionality with the
reconstituted biomolecular motor systems.
The challenge of cargo conjugation is addressed in this thesis through the
development of a robust bioorthogonal strategy to functionalize microtubules.
The versatility of the developed method is demonstrated by covalently conjugating
various types of cargos to microtubules. Further, the effect of the linker length
on cargo attachment to microtubules is investigated by attaching cargo to mi-
crotubules via linkers of different lengths. By using kinesin-driven transport of
microtubules that are covalently conjugated to antibodies, detection of various
clinically relevant analytes is demonstrated as proof-of-principle applications for
biosensing. Finally, the challenge of gaining control over transport directionality is
addressed through topographical guiding of microtubules in nanostructures, and
optimization of assay parameters to achieve successful guiding of microtubules.
Spatio-temporal analyte concentration, using transport in these nanostructues, is
also explored to make the biomolecular-motor based applications more suitable
for use real-world point-of-care setting.
Taken together, the experimental work in this thesis contributes to the field of
nanotechnological applications of biomolecular motors. The developed microtubule
functionalization method and understanding of the effect of cargo attachment via
linkers provide useful design principles for efficient cargo loading to microtubules.
Moreover, establishment of assay components for successful guiding of microtubules
in nanostructures is a vital step forward for practical translation of future nanoscale
devices.
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Introduction
Nature has evolved over billions of years to make life the wonder that it is. Cells,
the basic building blocks of life, are capable of carrying out a vast array of
complex functions with its elegantly evolved molecular machinery. For example,
biomolecular motor proteins, in conjunction with their associated cytoskeletal
filaments, constitute the highly-efficient intracellular transport system in the
cells. These proteins actively transport cellular cargo, position various cellular
components, and are key players in vital physiological functions such as cell division.
Taking inspiration from nature, an active area of nanotechnological research has
been focused at emulating nature’s machinery by reconstituting this highly efficient,
cellular transport in synthetic environments to develop novel applications. In
recent years, kinesin motor proteins along with microtubule filaments have proved
to be promising candidates for the development of such synthetic biohybrid
devices1–11. In this thesis, the quest to develop nanotechnological applications
with biomolecular motors is explored using the motor protein - kinesin-1 and its
associated cytoskeletal filament - microtubules.
1.1 The cellular cytoskeleton
The cytoskeleton of the cell is composed of an intricate network of filaments
(such as actin and microtubules) which constitutes the tracks over which the
motor proteins (such as myosin on actin, and kinesin on microtubules) transport
1
1. INTRODUCTION
cargo. In the following sections, an overview of the kinesin motor protein and the
microtubule filaments, which are used in this thesis, is presented.
Kinesin
Kinesin was discovered by Vale and colleagues in 1985 as the biomolecular motor
responsible for fast transport of organelles along the microtubules in the axons of
giant squids12. Based on the ability of this protein to induce motility, they named
it Kinesin (from the Greek word kinein, meaning “to move”). Since then, further
studies have led to the discovery of a large number of proteins that are structurally
and functionally similar to the first kinesin in various organisms. These proteins,
along with the kinesin reported by Vale et al. 12 (“Kinesin-1”), constitute the
kinesin superfamily of motor proteins.
Kinesin light chain 
(KLC)
Kinesin heavy chain 
(KHC)
motor 
heads
stalk
tail
neck
Figure 1.1: The structure of Kinesin-1 - Kinesin-1 is composed of two identical
kinesin heavy chains (KHC) and kinesin light chains (KLC). Adapted from Vale,
200313
The kinesins move along the microtubules to transport organelles, vesicles, and
other molecules, and also participate in spindle organization and the transport
and separation of chromosomes during cell division14–18. In this thesis, kinesin-1,
the first discovered as well as the best characterized kinesin, has been used and
will be further described. Kinesin-1 is a ∼ 360 heterotetrameric protein consisting
of two heavy chains (kinesin heavy chain or KHC, ∼ 120 kDa) and two light
chains (kinesin light chain or KLC, ∼ 60 kDa)19–21. The KHCs in turn consist of
N-terminal motor domains called “heads”, connected with a “neck linker”. This
2
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region is followed by a coiled-coil region called the “stalk” that facilitates the
dimerization of the protein22. The heavy chain terminates with the C-terminal
“tail” region, that connects to the KLCs. The tail is responsible for cargo binding;
in the absence of any cargo, the tail domain folds back and binds to the motor
heads23, rendering the motor inactive. The KLCs consist of N-terminal coiled-coil
domain, followed by a tetratricopeptide repeat and a C-terminal domain. The
domains of the KLC recognize and bind to different regions of the cargo and
facilitate cargo-transport by the motor (Figure 1.1).
Kinesin-1 moves to the plus end of a microtubule in a “hand-over-hand”
fashion24,25. It is a highly processive motor, enabling it to take several steps before
detaching from the microtubule. One of the two motor heads is always bound to
the microtubule26, while the other takes a 16 nm step by deriving energy from the
hydrolysis of one molecule of ATP to ADP23,27. Consequently, the motor covers a
distance of 8 nm for each molecule of ATP hydrolyzed. During its movement, a
single kinesin-1 molecule can exert a force upto 6 pN27,28. This results in an energy
production of 48 pN · nm per step of the motor, per molecule of ATP consumed,
corresponding to an incredibly high energy efficiency of ∼ 50 % for the conversion
of chemical energy of ATP to mechanical work.
Microtubules
Structure and dynamics
Microtubules are stiff, hollow cylindrical structures that provide mechanical
support to the cells to maintain their shapes. Additionally, they constitute the
tracks on which molecular motors, such as kinesin, transport their cargos inside
the cell.
Microtubules are polymers composed of α - and β - tubulin heterodimers.
The tubulin monomers (MW ∼ 55 kDa) share almost 50% homology in their
primary sequence29. Each of the α and β tubulin monomer binds to a GTP
nucleotide. The GTP bound to the α - tubulin is non-hydrolyzable, while that
bound to the β - tubulin can be hydrolyzed to GDP. To polymerize microtubules,
tubulin heterodimers with GTP bound to both α and β subunits assemble in a
head-to-tail manner to form polar protofilaments with α - tubulin exposed at the
3
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50 nm
10 nm
β
Tubulin
heterodimer
plus (+) end
Microtubule
25 nm
α
minus (-) end
8 nm
A
B
Figure 1.2: The structure of microtubule - (A) Microtubules are assembled
from tubulin heterodimers to form stiff hollow tube composed of 13 protofilaments.
(B) Electron micrograph of a short segment of microtubule (left image) and the
microtubule cross-section (right image). Adapted from Alberts,2004.
minus end and β - tubulin at the plus end. During this polymerization process,
the GTP bound to the β-subunit is hydrolysed to GDP, as the β-subunit of the
heterodimer binds to the α-subunit of the next heterodimer of the protofilament.
The protofilaments bind laterally to form a hollow cylinder with an outer diameter
of about 25 nm and inner diameter of about 15 nm30,31 (Figure 1.2). In vivo,
microtubules are predominantly composed of 13 - 14 protofilaments, while in vitro
the number of protofilaments in a microtubule can vary from 10 to 1526,31,32(179),
with most microtubules consisting of 14 protofilaments31.
Microtubules exhibit the phenomena of dynamic instability, characterized by
phases of slow growth and rapid shrinkage33. In a polymerizing microtubule, the
hydrolysis of the GTP at the plus end is slower than the rate of polymerization
(that is, addition of a new tubulin dimer)34,35. This results in the formation of a
GTP “cap” at the plus end, which stabilizes the growing microtubule. Loss of
the GTP cap, destabilizes the microtubule, resulting in depolymerization of the
microtubule (“catastrophe”). Reversal to a state of microtubule polymerization is
4
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possible through the attachment of sufficient tubulin dimers with non-hydrolyzed
GTP at the plus end (“rescue”). The dynamic instability of microtubules allows
cells to regulate microtubule length and distribution for reconfiguration of the
cytoskeleton during cell division or development36.
Chemical stabilization of microtubules in vitro
In vitro microtubules can be stabilized by various chemicals to slow down de-
polymerization. In this thesis, three different methods to grow and stabilize
microtubules have been used:
1. Microtubule polymerization with GTP, followed by stabilization with Taxol.
Taxol, a commonly used anti-cancer drug, stabilizes microtubules by pre-
venting GTP hydrolysis37,38.
2. Microtubule polymerization with slowly hydrolysable GTP analogues like
guanylyl-(alpha, beta)-methylene-diphosphonate (GMP-CPP). Stabiliza-
tion with GMP-CPP results in almost 5000 fold decrease in microtubule
depolymerization rate39.
3. Microtubule polymerization with GMP-CPP, followed by stabilization with
Taxol.
Polymerized microtubules can also be chemically cross-linked with glutaralde-
hyde to extend their lifetimes40.
1.2 Engineering nanotechnological applications
Owing to their small size, energy efficiency, and robustness in synthetic envi-
ronments kinesins and microtubules are an attractive choice for a wide range of
nanotechnological applications1–11. To reconstitute the biomolecular transport in
vitro, two types of assay geometries are commonly used:
5
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Stepping assay Gliding assay
+ end
Anti-tubulin 
antibodies
- end
Stepping Kinesin-1
(with fluorophore)
Propelled 
microtubule
BA
Immobilized 
Kinesin-1
Immobilized 
microtubule
+ end- end
Figure 1.3: In vitro reconstitution of biomolecular transport - (A) Step-
ping assay of fluorescent kinesin molecules walking on microtubules immobilized
with anti-tubulin antibodies. (B) Gliding assay of microtubules propelled over a
surface of immobilized kinesin-1 motors.
Stepping assay Here, microtubules are immobilized on a surface (via anti-
tubulin antibodies or other means) and the kinesin motors move over them
(Figure 1.3A). This assay geometry has been used to transport cargos such as
beads41, nanosphere40, oil droplets42 along the surface immobilized microtubules.
The distance through which the cargo gets transported depends on the length of
the microtubule over which the cargo-transported kinesins are moving, unless the
immobilized microtubules are overlapping.
Gliding assay Also called “inverted motility assay”, the microtubules are
transported in this case over a surface of immobilized kinesin motors43(Figure
1.3B). As the microtubules are propelled by the collective action of multiple
motors, this assay results in more robust cargo transport via cargo conjugated
microtubules. Consequently, this geometry is a popular choice for biomolecular
motor-based nanotechnological applications, and is used in this thesis.
Engineering challenges
Reconstitution of biomolecular motor and microtubule motility in vitro has
resulted in the development of a wide range of nanotechnological applications.
This energy-efficient, nanoscale system has been used as molecular transporter
for cargo loading and unloading7,11, molecular sorting9, surface imaging44, and
6
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biosensing6,45. However, there have been two major challenges to the development
of these biomolecular-motor-based applications: 1. Development of successful
cargo conjugation methods, 2. Achieving control of the microtubule transport
Antibody-conjugated 
MT
Antibody-conjugated 
MT
 MT with biotin
Antibody conjugation
 via biotin-streptavidin
A B Antibody conjugation 
via covalent bonding
1 covalent bond
2 non-covalent 
bonds 
 MT with reactive group
 Antibody 
with 
complementary 
reactive 
group 
 + Streptavidin
 + Biotin 
conjugated
antibody
Figure 1.4: Comparison of schemes
to conjugate cargo (here, antibod-
ies) to microtubules using A. biotin-
streptavidin (left) and B. covalent con-
jugation (right). - In case of A, antibodies
are attached to the microtubule via two non-
covalent bonds between biotin-streptavidin,
each with its characteristic dissociation con-
stant. On the other hand, for B, the anti-
bodies are attached to the microtubule via
single covalent bond, yielding a stable con-
jugate.
Cargo conjugation strategies
Attachment of cargo to microtubules
is crucial for the development of a
vast majority of biomolecular motor-
based nanotechnological applications.
Ideally, the bioconjugation strategy
used to conjugate cargo to micro-
tubules should be facile, specific, ef-
ficient, and applicable for the attach-
ment of a wide range of cargo, with-
out compromising the activity of the
biomolecules involved (kinesin, micro-
tubule, etc.).
Over the years, cargo conjugation
to microtubules has been achieved
by employing both non-covalent and
covalent strategies. Until now, the
non-covalent interaction between bi-
otin and streptavidin has been the
most popular choice for cargo con-
jugation1,2,4,5,7–11. Despite being the
strongest non-covalent bond known,
with dissociation constant (Kd) of
1015M 46,47, the biotin-streptavidin
linkage is limited by non-specific clus-
tering and aggregation48,49, and de-
creased lifetime of the bond under
tension50–52. Cargo loading to mi-
crotubules has also been achieved using DNA hybridization11,53–56. As the
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DNA strands were conjugated to the cargo and/or microtubules via biotin-
streptavidin linkage, these applications were limited by the drawbacks intrin-
sic to the biotin-streptavidin bond. Covalent approaches were used to modify
microtubules by chemically cross-linking microtubules with glutaraldehyde6, func-
tionalizing microtubules with succinimidyl-4-hydrazidoterephthalate (SHTH)57 or
N-hydroxysuccinimidyl (NHS)-ester agents. These chemicals modify the primary
amino acids of any protein, and are therefore non-specific in nature. Site-specific
cargo conjugation to microtubules was achieved by expression and purification of
non-natural amino acid incorporated recombinant tubulin, followed by selective
modification of these residues to allow bioorthogonal “click” reaction for cargo
attachment58. However, successful expression of recombinant tubulin is limited
by low yield and tubulin aggregation59, which in turn limits the practical appli-
cability of any recombinant-tubulin based cargo loading strategy. Früh et al. 60
applied bioorthogonal “click chemistry” to successfully conjugate fluorescent dye
to microtubules in a gliding motility assay. Their reaction was based on the
strain-promoted alkyne-azide cycloadditions (SPAAC) reaction between azide and
strained alkyne. Bioorthognal reactions provide exquisite selectivity in chemically
modifying biomolecules without interference or side-reaction with the functionali-
ties present in the biological system (thus are orthogonal to intrinsic biological
reactions). Despite the selectivity, SPAAC reactions are limited by their slow
kinetics (k < 1 /M/s compared to kon ∼ 105−106M−1s−1 for affinity-ligand-based
reactions)61,62. For practical applications of bioorthogonal reactions, kinetic rates
of k ∼ 103M−1s−1 and higher are deemed critical63. In this thesis, inverse elec-
tron demand Diels-Alder (iEDDA) bioorthogonal reaction between tetrazine and
trans-cyclooctene - the fastest currently known bioorthogonal reaction - will be
employed to covalently conjugate various types of cargo to microtubules.
Control of transport directionality Unlike the highly-specific directional
motor transport in vivo, reconstituition of biomolecular motor-based transport in
vitro lacks directionality. Precise control of the direction of transport is critical
for further exploitation of the advantages of biomolecular system in vitro and to
translate the reported proof-of-principle applications to a practical setting.
8
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Over the years, various approaches were undertaken by different groups to
achieve control over microtubule motility for nanoscale transport. Initial attempts
focused on depositing kinesin coated poly(tetrafluoroethylene) (PTFE) films64,
or using microtubules templates to “print” kinesin onto a glass surface65 that
restricted the motion of the microtubules along the films’ orientation axes or
the printed kinesins respectively. While linear control of microtubules motion
was achieved with these methods, unidirectional transport could not be attained.
Later, Clemmens et al. 66 used chemical patterning to create alternating kinesin-
coated and kinesin-free tracks, and quantified how well the microtubule gliding was
confined within the kinesin coated tracks. They observed that the angle at which a
microtubule moving in the kinesin-coated track approached the boundary between
kinesin-coated and non-coated surface decided the probability of the microtubule
to be guided in the desired track. The higher the approach angle, lower is the
probability of the microtubule to follow the track and be guided by the chemical
patterning. Several groups demonstrated control of microtubule movement by
steering the intrinsically negatively charged microtubules with electric field67–69, or
by using magnetic fields to steer CoFe2O4 functionalized tip of the microtubule
8.
Shear flow has also been used to orient the microtubules in a flow channel and
impart directionality to their movement70,71. Another strategy involved fabrication
of microlithographic tracks and physically restricting the movement of microtubule
within them. Microtubules were successfully guided in topographical structures
comprising open channels of few micrometers delineated by boundary walls several
hundred nanometers high3,9,66,72–77. Unidirectional motion of gliding microtubules
was achieved by using “rectifier” geometries to guide the microtubules approaching
the boundary wall3,72,74. Introduction of overhangs on the boundary wall further
prevented the loss of approaching microtubules, improving the guiding efficiency of
the structures78. In this thesis, lithographically patterned channels, modified with
selective surface chemistry, will be used to impart directionality to microtubule
movement.
9
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1.3 Motivation
The field of nanotechnological applications of biomolecular motors is a young
and evolving area of research. While the field has advanced significantly in the
recent decades, it is fraught with several engineering challenges (see 1.2). The
overarching goal of this thesis is to address some of these current challenges and
following that, demonstrate proof-of-principle applications of microtubules and
kinesin-1 motors aimed particularly at analyte detection applications.
Of these, the establishment of robust bioconjugation strategies to modify
microtubules can provide the much-needed impetus to drive the development
of novel applications with microtubules and kinesin motors, particularly for
cargo-transport based applications. This is the first engineering challenge that is
addressed in this thesis, through the development of a bioorthogonal strategy to
functionalize microtubules that overcomes the limitations of the non-covalent cargo
conjugation schemes currently used in the field. The developed bioconjugation
scheme is then utilized to successfully demonstrate several analyte detection
applications.
The second engineering challenge addressed in this thesis is aimed at controlling
the directionality of reconstituted microtubule motility to generate useful transport.
Fundamental parameters of the reconstituted assay are probed to determine factors
that influence successful guiding of microutbules in lithographically patterned
nanostructures. Following this optimization, the guided microtubule movement in
the nanostructures is employed to achieve spatio-temporal analyte concentration
and analyte detection.
1.4 Outline of the thesis
In chapter 1, the motor protein - kinesin-1 (referred to as “kinesin” from now
on), and its associated cytoskeletal filament - microtubules were introduced, along
with the assay setups used to engineer nanotechnologcal applications with these
components. The chapter concluded with a review of the current engineering
challenges to the development of these applications, along with relevant examples.
10
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The subsequent chapters of the thesis are aimed at addressing these engineering
challenges mentioned.
In chapter 2 of the thesis, a versatile bioorthogonal strategy to covalently
conjugate various types of cargo to microtubules is developed. Thereafter, using
the developed conjugation strategy, the effect of linker length on cargo attachment
to microtubules is investigated. The results from this chapter provides useful
design principles to strategize suitable cargo conjugation scheme to microtubules
based on the desired application.
In chapter 3, microtubules with covalently conjugated antibodies (using the
method developed in chapter 2) are used in a kinesin gliding motility assay to
develop proof-of-principle biosensing applications. Detection of various clinically
relevant analytes is reported using fluorescence-based as well as label-free detection
methods.
Finally, chapter 4 of the thesis investigates the fundamental aspects of the
gliding motility assay in lithographically patterned nanostructures. As these
structures aim to bridge the current gap at translating the proof-of-principle
applications to a practical point-of-care setting, a comprehensive understanding of
the basic assay features is undertaken in this chapter that provides useful insights
to the development of future nanotechnological applications with biomolecular
motors.
11
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Bioorthogonal cargo conjugation
to microtubules
Transport systems based on biomolecular motors are promising components for
developing nanoscale devices79,80 due to their small-size, energy efficiency,81 and
detection sensitivity45,82. A critical requirement for vast majority of these appli-
cations is the development of effective microtubule functionalization schemes that
ensure reliable cargo loading. Ideally, such schemes are simple, robust, and appli-
cable to a wide range of cargo. Traditionally, the most common method of cargo
attachment to microtubules has been using the biotin-streptavidin linkage1,2,4,5,7–11.
Here, a novel bioconjugation strategy is presented to covalently couple cargo to
microtubules using the recently developed inverse-electron-demand Diels-Alder
addition (iEDDA)83,84 reaction between tetrazine and trans-cyclooctene (TCO)
(Figure 2.1). Besides retaining the advantages of “click chemistry” (including
high reaction specificity, and biocompatibility), iEDDA reactions proceed at un-
precedented speed (k > 800M−1s−1, faster than any other known bioorthogonal
reaction) in a wide range of solvents, and do not require catalysts. Moreover, the
recent commercial availability of a wide range of tetrazine and TCO reagents has
made iEDDA reactions a popular choice for bioconjugation applications.
Conjugation of two types of cargos - monoclonal IgG antibodies and fluorescent
streptavidin - using the TCO-tetrazine bioorthogonal reaction is described. These
cargo conjugated microtubules are then used in a kinesin gliding motility assay for
the development of various nanotechnological applications in the next chapters.
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Figure 2.1: Bioconjugation Scheme - Inverse electron demand Diels Alder
(iEDDA) reaction between trans-cyclooctene (TCO) functionalized biomolecule A
and methyl-tetrazine functionalized biomolecule B.
Previous studies have shown that cargos attached to the microtubules act as
obstacles to the kinesin motors that propel the microtubules in a gliding motility
assay85,86. This phenomenon, called the “roadblock effect”, occurs as the cargo
hinders the access of the motor heads to their binding site on the microtubules,
effectively decreasing the rate at which the motors propel the microtubules forward.
The gliding velocity of cargo-conjugated microtubules can go down to as low
as 10% of its velocity in the absence of any cargo85,86. Despite the scope of
applications with biomolecular motors in vitro, this compromised transport of
microtubules on cargo attachment constitutes a major bottleneck in the field.
While a high density of cargo, such as antibodies, on the surface of the microtubules
is desirable for various applications, such as biosensing and analyte detection, the
corresponding decrease in microtubule velocity with cargo attachments impairs
the development of fast detection assay45. To overcome these limitations, an
alternative strategy to circumvent the “roadblock effect” was explored by attaching
cargo to the microtubules via long flexible poly-ethylene glycol (PEG) linkers
using the developed bioconjugation method.
Publication Results from this chapter (section 2.1) and the next chapter (sec-
tion 3.1) have been published as: Tetrazine-trans-cyclooctene-mediated conjugation
of antibodies to microtubules facilitates sub-picomolar protein detection. S. Chaud-
huri, T. Korten, and S. Diez. Bioconjugate Chemistry, 28 (4), 918–922 (2017).
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2.1 trans-cyclooctene functionalization of micro-
tubules
To obtain TCO-functionalized microtubules, tubulin was labeled with TCO-
(PEG)x-NHS (where x = 0, 4, 12) by modifying the solvent accessible amino
groups of the protein (Figure 2.2A. For details see Section 6.3). Taxol-stabilized
microtubules were polymerized from a 4:3:1 mixture of TCO-(PEG)x-tubulin,
unlabeled-tubulin, and rhodamine-tubulin, and used in a kinesin gliding assay.
NH
2
NH
2
NH
2
TCO-PEGx-NHS 
Atto488-tetrazine
=
=
Kinesin-1 Kinesin-1 
 TCO-PEGx-MTMT
A
B
Figure 2.2: Functionalization of microtubules with trans-cyclooctene
(TCO) - (A) Functionalization scheme. Solvent accessible amino groups of tubulin
were modified by TCO-(PEG)x-NHS (x = 0, 4, 12). (B) Scheme for confirmation
of TCO-functionalization of microtubules in a kinesin gliding motility assay. To
confirm successful labeling, microtubules were polymerized from a 4:3:1 mixture
of TCO-(PEG)x-tubulin, unlabeled-tubulin, and rhodamine-tubulin, and used in
gliding motility assay where 1 µM Atto488-tetrazine dye was added to confirm the
presence of the TCO groups on the microtubules.
For developing gliding-assay-based applications with functionalized micro-
tubules, two important criteria need to be fulfilled: (i) the chemically-modified
tubulin should retain its ability to polymerize into microtubules and (ii) the
polymerized microtubules in turn should retain their ability to glide over the
kinesin surface. To confirm the successful labeling and the accessibility of the
TCO-groups on these microtubules, 1 µM fluorescent Atto488-tetrazine dye was
added in the gliding motility assay (Figure 2.2B). Following 10 min incubation,
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the excess dye was washed off, and the fluorescence intensity of the dye per
unit length of the TCO-(PEG)x-microtubules, as well as the gliding velocity of
these microtubules, was evaluated. Control microtubules polymerized from Cy5-
labeled tubulin were also added to the assay with the TCO-(PEG)x-microtubules.
Figure 2.3A shows the plot of microtubule gliding velocity (black data points)
and the corresponding signal from Atto488-tetrazine dye (green data points) for
different TCO-(PEG)x-microtubules and the control microtubules. The gliding
velocities of the TCO-(PEG)x-microtubules were similar to that of the control
microtubules, in agreement with previous reports showing that functionalization
with small amine-reactive reagents does not significantly affect the gliding motility
of microtubules6,60,87. However, the signal from the fluorescent tetrazine-dye
was found to increase with the increase in number of PEG-units present in the
TCO-(PEG)x-microtubules. The fluorescence images of the microtubules (in red)
and the signal from the Atto488-tetrazine dye (in green) also showed an increase in
signal from the dye for the TCO groups attached via longer linkers (Figure 2.3B ).
Moreover, as the length of the linker increases from 0 PEG units to 12 PEG units,
a corresponding increase in the labeling efficiency was observed as quantified from
the 4 fold increase in fluorescence signal from the tetrazine dye. These results
demonstrate that the presence of a long, flexible PEG linker enhances the labeling
efficiency of small-molecule functionalization of tubulin.
Long term storage of PEG-functionalized proteins is often problematic due
to the loss of polymeric PEG backbone through oxidation and/or hydrolysis88.
As the problem is putatively exacerbated by longer length of the PEG chain, the
TCO-group with optimal number of PEG linker units was chosen for labeling
tubulin. While the presence of longer PEG linker attached to the TCO group
was found to improve the labeling, the labeling observed with linker consisting of
4 PEG units was already several fold higher than that without any PEG linker.
Therefore, as a 4 unit PEG linker reagent is expected to have better long-term
stability over a 12 unit PEG linker reagent, TCO-(PEG)4-NHS labeled tubulin
was used for conjugating tetrazine-modified cargo in the following sections.
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Figure 2.3: Characterization of the TCO-(PEG)x-functionalized micro-
tubules in kinesin gliding motility assay - A. Gliding velocity of the micro-
tubules and the amount of TCO on the microtubule surface. Gliding velocities
(black data points) of microtubules polymerized from 4:3:1 mixture of TCO-(PEG)x-
tubulin, unlabeled-tubulin, and rhodamine-tubulin showed that the gliding velocity
was unaffected by the labeling. The amount of TCO groups on the microtubule
surface, as quantified from the fluorescence intensity of the Atto488-tetrazine dye
(green data points) per unit length of the microtubule, increased as the number
of PEG units via which the TCO group was attached increased. Data (mean ±
standard deviation) evaluated for 28 – 57 microtubules. B. Fluorescence images of
the microtubules (red) and the corresponding signal from the Atto488-tetrazine dye
(green). The control microtubules without the TCO group showed no signal in the
green channel, while the signal from the TCO-(PEG)x-microtubules increased with
the increase in number of PEG units in the linker. Thus, increase in the length of
linker for attachment of the TCO group to the microtubules enhances the labeling
efficiency. Scale bar 10 µm.
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2.2 Attachment of antibodies to microtubules
for analyte detection
To generate antibody-conjugated microtubules (Ab-MTs), tetrazine-(PEG)5-
modified mouse IgG antibodies were covalently coupled to rhodamine and TCO-
(PEG)4-colabeled microtubules (TCO-MTs) using the bioorthogonal iEDDA reac-
tion (Figure 2.4A). To confirm successful conjugation, 100 nM Alexa Fluor 488
anti-mouse secondary antibodies were added to the Ab-MTs surface-immobilized
by anti-rhodamine antibodies (Figure 2.4B). Rhodamine-Cy5-colabeled, non-TCO-
functionalized microtubules that lacked the tetrazine-modified antibodies were
used as control. After 30 min incubation and subsequent washing, specific co-
localization of the fluorescent Alexa Fluor 488 signal from the secondary antibodies
to the Ab-MTs confirmed successful conjugation (Figure 2.4C). The high intensity
and uniform distribution of the co-localized signal indicate a high labeling density
of the Ab-MTs. This can be ascribed to the efficiency of the iEDDA reaction,
enabling high conjugation of antibodies to the microtubules. Additionally, the
presence of short PEG linkers on both the TCO and the tetrazine groups po-
tentially contributes to accentuating the conjugation efficiency by increasing the
accessibility to the binding sites.
Next, the Ab-MTs were used in a kinesin gliding motility assay (Figure 2.4D).
The Ab-MTs retained their ability to glide over the kinesin surface, albeit with a
velocity (626 ± 67 nm/s) lower than that of the microtubules lacking antibodies
on their surface (774 ± 32 nm/s for control MTs; 760 ± 56 nm/s for TCO-MTs)
(Figure 2.4E ). This effect on the gliding velocity is consistent with earlier reports
of lowered gliding velocity of microtubules in the presence of “roadblocks” on
their surface, although the decrease in the gliding velocity is not as drastic as
was expected from those studies. The assembled Ab-MTs gliding over a surface
of kinesin motors in the presence of ATP constituted the biosensing platform,
where the antibodies conjugated to the microtubules surface can specifically detect
analyte that has the complementary antigen on their surface.
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Figure 2.4: Covalent conjugation of antibodies to microtubules - A.
trans-cyclooctene (TCO) conjugated microtubules (TCO-MT) were polymerized
from TCO-tubulin, rhodamine-tubulin and unlabeled tubulin mixed in 4:1:3 ratio.
Tetrazine-conjugated anti-CD45 mouse IgG antibodies were covalently coupled to
the TCO-MTs via TCO-tetrazine bioorthogonal reaction, to generate antibody-
conjugated microtubules (AB-MTs). (B, C) The Ab-MTs (red) and the control
MTs (cyan) were immobilized on glass surface using anti-rhodamine antibodies.
100 nM fluorescent Alexa Fluor 488 anti-mouse secondary antibodies were added to
these stationary microtubules, incubated for 30 min, and washed off. The specific
co-localization of the fluorescent secondary antibody signal to the Ab-MTs, and not
to the control MTs demonstrate successful conjugation of tetrazine antibodies to the
TCO-MTs. Scale bar 5 µm. (D, E) The Ab-MTs, the TCO-MTs and the control
MTs were used in a kinesin gliding motility assay. The gliding velocity (mean ±
s.d.) of the Ab-MTs (626 ± 67 nm/s) was lower than that of the TCO-MTs (760 ±
56 nm/s) and the control-MTs (774 ± 32 nm/s).
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2.3 Attachment of streptavidin to microtubules
for roadblock studies
Streptavidin was modified using tetrazine-(PEG)5-NHS and covalently conjugated
to the TCO-MTs (Figure 2.5A) . Two types of fluorescent streptavidins were
used to conjugate to microtubules - Alexa Fluor 647 Streptavidin and Fluorescein
streptavidin.
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Figure 2.5: Covalent conjugation of streptavidin to microtubules - A.
Tetrazine-conjuagted streptavidin was colavently conjugated to TCO-MTs using
biorthogonal reaction. B. The streptavidin conjugated microtubules (SA-MTs) were
then used in kinesin gliding motility assay. C. Fluorescence images of different
streptavidin conjugated microtubules shows successful conjugation of the fluorescent
streptavidins to the microtubules. D. Gliding velocities of the SA-MTs are similar
to that of the control-microtubules.
The streptavidin-conjugated microtubules were then evaluated in a kinesin
gliding motility assay (Figure 2.5B). Cy5 -labeled microtubules were used as
control in the same assay. Specific co-localization of fluorescence signal from the
streptavidin to the TCO-MTs confirmed successful conjugation (Figure 2.5C).
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Surprisingly, the gliding velocity of the streptavidin conjugated microtubules
(for both types of fluorescent streptavidins) was found to be similar that of
the control microtubules that lacked any streptavidin on their surface (2.5D).
This observation is in contrast with previous “roadblock” studies that showed
conjugation of streptavidin to microtubules led to dramatic decrease in microtubule
gliding velocity85,86.
To explain this apparent discrepancy, it is important to understand the nature
of the streptavidin-biotin interaction and how the streptavidin binds to the
microtubules in these assays. Streptavidin is a homotetrameric protein that binds
with exceptional affinity to the small biotin group (Kd 10
−14M ; strongest known
non-covalent interaction)89. Structurally, streptavidin can be approximated as a
cuboid of 5.4 nm x 5.8 nm x 4.8 nm dimension, with the biotin binding sites buried
1.7 nm or 1.9 nm (depending on the side) deep inside the streptavidin core90–92
(Figure 2.6A). A key difference between the previously reported streptavidin-
microtubule setups and the one developed in this thesis lies in the length of the
linker separating the streptavidin from the microtubule surface. The previous
setups used biotinylated microtubules in which the biotin was conjugated to the
tubulin via an approximately 3.05 nm long spacer arm; the streptavidin would
bind to these biotins on the microtubule surface. As the biotin binding sites are
located roughly 2 nm inside the streptavidin core, this means that the effective
distance at which the streptavidins were held from the microtubule surface in
these assays was around 1 nm (Spacer arm - depth of biotin binding pocket; see
Figure 2.6B (left)). In the assay used in this thesis, the streptavidin is covalently
conjugated to the microtubules using a bioorthogonal reaction between tetrazine
functionalized streptavidin and TCO-functionalized microtubule, each with 5
and 4 PEG units respectively (Figure 2.6B (right)). As a result, in this case,
the distance at which the streptavidin is held from the microtubule surface is
the sum of the lengths of the both the conjugating groups and their linkers
(that is, TCO-(PEG)4 + tetrazine-(PEG)5), which is around 5-7 nm (from the
structural information provided by vendors). The non-reduction of microtubule
gliding velocity in the case where streptavidin cargo is held at this relatively
longer distance indicates that the long linker attached to the cargo circumvents
the “roadblock effect”. Interestingly, this distance falls in the same range as the
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dimensions of the kinesin motor head93. Attachment of cargo via a linker of
comparable dimension or longer than the motor head can, therefore, facilitate the
access of the kinesin motor heads to their binding sites on the microtubule even
in the presence of a high density of the cargo. This explains the gliding velocity
of the streptavidin-conjugated microtubules in the current setup. Additionally,
this provides an explanation for the effect in gliding velocity observed in the
previous section for antibody-conjugated microtubules assembled with the same
bioorthogonal strategy. Antibodies (MW ∼ 150 kDa) are almost three times
the size of streptavidin proteins (MW ∼ 50 kDa). So while the long linker does
mitigate some of the roadblock effects, the large sized antibody-cargos offer more
resistance than the streptavidins to the access of the kinesin motor head binding
sites on the microtubules. As a result, the microtubule gliding velocity is decreased,
although not to the same extent as would be expected from the previous reports
where cargo was conjugated with very short linkers.
The covalently conjugated streptavidin to microtubules constitutes an excellent
system for studying how different motors navigate obstacles in vitro on the
microtubule surface. As different purified motor proteins often work optimally with
different buffers, the covalently conjugated streptavidins can act as “permanent
roadblocks” for biophysical characterization of motor movement in different buffer
systems. From a biological perspective, these minimal reconstituted systems can
offer understanding on how the motor proteins go around roadblocks in the highly
crowded environment of the cell.
Additionally, as the covalent attachment of cargo to microtubules via long
flexible linker leads to circumvention of the “roadblock effect”, it it interesting
to investigate the details of this phenomenon. In the next section, the effect of
linker length on cargo attachment to microtubules is investigated by conjugating
fluorescent streptavidin to microtubules via flexible PEG linkers of different
lengths.
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Figure 2.6: Streptavidin and its attachment to biotin-tubulin - A. Strep-
tavidin is cuboid in shape with the biotin binding sites located 1.7 - 1.9 nm inside
the protein. B. Attachment of streptavidin to biotin-tubulin (left) and covalent
conjugation of tetrazine-streptavidin to TCO-tubulin (right).
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Figure 2.7: Scheme showing attachment of fluorescent streptavidin to
biotinlyated microtubules in a gliding motility assay - Biotinylated micro-
tubules were prepared by covalently conjugating tetrazine-Biotin-PEGy to TCO-
PEGx-labeled microtubules. Fluorescent streptavidin was added to bind to these
biotins attached via linker of (x+ y) PEG units on the microtubules.
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2.4 Cargo attachment to microtubules via flex-
ible linker circumvents the roadblock effect
Biotin-conjugated microtubules (Biotin-MT) were polymerized from a 4:1, 1:1, 1:4
mixture of TCO-(PEG)x-tubulin (see section 2.1) and Alexa Fluor 488 tubulin,
followed by incubation of these microtubules with Biotin-PEGy-tetrazine (x = 0,
4, 12; y = 0, 2, 4, 6). These Biotin-MTs (at 80%, 50%, and 20% biotinylation
ratios) with various lengths of the PEG linker were then added to a kinesin gliding
motility assay, along with control Cy5-microtubules. Alexa Fluor 546 Streptavidin
(SA546) at 10 µM concentration was added to these microtubules, incubated for
10 minutes, followed by washing off of the excess, unbound SA546 (Figure 2.7).
The amount of SA546 that binds to the Biotin-MT and the corresponding gliding
velocity of these microtubules were quantified as a function of the total PEG
linker length.
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Figure 2.8: Microtubule gliding velocities and amount of fluorescent
streptavidin loaded on 80% biotinylated microtubules for various linker
lengths - A. Relative gliding velocity of streptavidin-loaded biotinylated micro-
tubules as a function of the total PEG units in the linker. For 0 PEG units, the
gliding velocity is unaffected. Thereafter, as the linker length increases, the relative
gliding velocity of the microtubules also increase. B. Fluorescence intensity (F.I.)
of the loaded streptavidin per unit length of microtubule as a function of the total
PEG units in the linker (green) increases with the increase in the linker length.
The relative gliding velocity data is plotted in grey for each data point (mean ±
standard deviation).
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Figure 2.8 shows the data evaluated from gliding motility assay with SA546
loaded Biotin-MTs at 80% biotinylation ratio (corresponding to the highest cargo
density). Figure 2.8A shows the plot of the relative gliding velocity of the SA546
loaded Biotin-MTs versus the total PEG linker length. At 0 PEG units, the gliding
velocity of the microtubules was similar to that of the control microtubules without
the SA546 cargo. Thereafter, the relative microtubule velocity drops as the PEG
units in the linker increases. However, after 6 PEG linker units, the relative
gliding velocity of the cargo-conjugated microtubules increases, and plateaus off as
the number of PEG units reaches 12. Figure 2.8B plots the fluorescence intensity
(F.I.; green data) from the cargo (SA546) as a function of the linker length. In the
background, the relative microtubule velocity as a function of the linker length is
plotted in grey. The increase in the number of PEG units of the linker results in
a corresponding increase in the F.I.. When the number of PEG units is 0, the
very low F.I. shows that there is very less cargo loading in this case. The low
amount of attached cargo is insufficient to have any significant roadblock effect,
which explains why the microtubule gliding velocity is unaffected in the case of
0 linker unit. As the number of PEG units increase, the amount of cargo that
gets attached increases linearly (linear fit R2 = 0.92). Thus, the linker length of
the cargo affects two aspects of the gliding motility assay: the amount of cargo
attached (enhanced by increasing the linker length), and the transport velocity of
the cargo-conjugated microtubules (increases with the linker length, expect for 0
linker length).Similar evaluations of the data obtained from gliding motility assay
with SA conjugated Biotin-MTs at 50% and 20% biotinylation ratios are shown
in Figure 2.9A and Figure 2.9B respectively. The observed trends were similar to
that of the data-set at 80% biotinylation ratio.
Figure 2.10 shows the plot of F.I. versus linker length for all the data-sets. For
each data point, the corresponding relative microtubule velocity is represented by
a colour of the heat map. The blue, red, and yellow lines represent 80%, 50%, and
20% biotinylation ratios respectively. For a given biotinylation ratio, the amount
of cargo attached increases with the increase in the linker length, as observed from
the increase in F.I. values. For a given linker length, as the biotinylation ratio
increases from 20% to 80%, there is a increase in the amount of cargo attached
while the relative gliding velocity of the microtubules decreases. This trend was
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Figure 2.9: Microtubule gliding velocities and amount of fluorescent
streptavidin loaded on 50% and 20% biotinylated microtubules for vari-
ous linker lengths - Fluorescence intensity (F.I.) of the loaded streptavidin per
unit length of microtubule (green data points) and the relative microtubule velocities
(grey data points) plotted as a function of the total PEG units in the linker for 50%
(A) and 20% (B) biotinylated microtubules (mean ± standard deviation).
found to be consistent across all linker lengths, except at 0 PEG units, at which the
very low F.I. value indicates negligible cargo attachment with no observed effect
on the gliding velocity at all three biotinylation ratios. This observation at 0 linker
length can be explained as follows: the biotin binding sites are situated 1.7-1.9
nm deep inside the streptavidin core. For the biotin attached to the microtubules
via linkers shorter than this length, the biotin is unable to access the binding
sites within streptavidin, impairing successful binding of streptavidin to these
biotinylated microtubules. As the linker length increases, the biotin can access
these sites, and successfully bind to the streptavidin; this binding was enhanced
with increased linker length. The long and flexible linkers offer greater degree
of freedom to the biotin conjugated to the microtubules, allowing them to have
better access, and subsequently better binding, to the biotin-binding sites inside
the streptavidin.
The effect on microtubule gliding velocity for increased biotinylation ratios at
a given linker length is consistent with the previous reports on the “roadblock
effect”, where increased amount of attached cargo on the microtubules leads
to a corresponding decrease in the microtubule gliding velocity. However, it is
interesting how this effect manifests with changes in the length of the linker via
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Figure 2.10: Combined plot of fluorescence intensity of the loaded strep-
tavidin and relative microtubule gliding velocity as a function of the
linker length - Fluorescence intensity (F.I.) of the loaded streptavidin per unit
length of the microtubule is plotted (mean ± standard deviation) as a function of
the linker length for all three microtubule biotinylation ratios. The diamond, square,
and circle points corresponds to data from 80%, 50%, and 20% biotinylation ratios
respectively. The relative gliding velocity of the microtubules is represented by a
colour of the heat map (right of the graph). The green box shows all data points
with similar amount of loaded streptavidin on the microtubules, corresponding to
400 − 600counts/µm F.I. values.
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which the cargo is attached to the microtubules. For linker length upto 10 PEG
units, the relative microtubule gliding velocity decreases from around 80% to
almost 20% of its initial velocity for increase in biotinylation ratio from 20%
to 80%. For 2-10 PEG units in the linker length, a small increase in the cargo
loading to the microtuble led to a drastic decrease in the gliding velocity. For
cargo attached via linker with more than 10 PEG units, the decrease in gliding
velocity with increased cargo loading was less dramatic. Going from 20% to 80%
biotinylation ratio for > 10 PEG units of linker length, the relative reduction
in the gliding velocity decreased as the linker length increased. To put this in
context, at 6 units of PEG linker, the relative gliding velocity decreased from
∼ 70% to ∼ 30% from 20% to 80% biotinylation ratio; at 18 units of the PEG
linker, the velocity decreased from 90% to ∼ 75% for 20% and 80% biotinylation
ratios respectively. Interestingly, the amount of cargo on the microtubules at 80%
biotinylation ratio for the 18 unit linker was > 3 times that on the microtubules
for the 6 unit linker. The green box in Figure 2.10 shows the data for F.I. in the
range of 400 − 600 counts/µm. For this F.I range, that is, at similar amount of
loaded cargo on the microtubules, as the linker length increases, the microtubules
glide faster.
The total length of the linkers94 can be estimated by multiplying the number of
PEG units with the Kuhn length of PEG95. The 6 PEG units linker corresponds
to a length of ∼ 4 nm, while that of 12 and 18 units are ∼ 8 nm and ∼ 12 nm
respectively. As described above, it was from 12 units of linker length that the
“roadblock effect” was increasingly circumvented. Interestingly, the dimensions of
kinesin motor head are estimated to be around 8 nm93, which is in the same range
as that of the 12 unit PEG linker. Taken together, these results indicate that as
the length of the linker becomes equal to or larger than the dimensions of the
kinesin motor head, the access of the kinesin motor heads to their binding sites
on the microtubule is facilitated despite the presence of a high-density of cargo.
Thus, attachment of cargo via long flexible linker can effectively circumvent the
“roadblock effect” while additionally enhancing the efficiency of cargo-loading to
the microtubules.
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2.5 Conclusion
In this chapter, a novel method of cargo conjugation to microtubules in vitro was
presented. The method used the tetrazine-trans-cyclooctene reaction, the fastest
known bioorthogonal reaction, to covalently conjugate cargos to microtubules.
Antibodies were conjugated to the microtubules to develop biosensing platforms
for detection of different analytes. Fluorescent streptavidin was conjugated to
the microtubules to serve as “permanent roadblocks” for characterization of the
behaviour of different motors on encountering obstacles. Moreover, by conjugating
streptavidin cargo to microubules via flexible PEG linkers of different lengths, the
effect of linker length on cargo attachment and transport were investigated. It was
shown that increase in linker length enhances the cargo-loading on the microtubules,
and that cargo attachment via long linker can effectively circumvent the “roadblock
effect” to rescue the velocity of cargo-conjugated microtubules in gliding motility
assay. These results advance the current understandings on the transport of cargo-
conjugated microtubules by kinesin motors, and provide useful design principles
for the choice of suitable linker for cargo attachment to microtubules. Additionally,
the described conjugation scheme can be easily adapted for loading other types
of cargos, as iEDDA reactions have been shown to be compatible with a wide
range of biomolecules. Because the iEDDA chemistry is orthogonal to other “click
chemistry” schemes, it will open new opportunities for the simultaneous and
sequential assembly of multiple modular units to microtubules in gliding motility
assays.
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Analyte detection with
antibody-conjugated
microtubules in gliding motility
assay
Lab-on-chip devices have emerged as promising miniaturized analysis systems
for chemical and biological applications in the recent years. Development of
cost-effective, small and portable in vitro diagnostics devices for the diagnosis and
treatment of diseases is currently changing the landscape of healthcare delivery.
In clinical diagnostics, miniaturization helps by reducing the amount of sample
required, shortening the analysis time and allowing increased throughput and
automation. Portability allows point-of-care diagnosis even in non-clinical setting,
improving access to healthcare and personalization of treatment.
Microfluidics has been the strongest enabling technology for the development
of these miniaturized devices. Over the last years, several microfluidics-based
diagnostics solutions have become popular in the market, such as, the Micronics
PanNAT Molecular Diagnostics System for nucleic acid based immunoassays96,
the Alere Triage Cardiac Panel for the diagnosis of acute myocardial infarction? ,
and Abbott’s i-Stat handheld blood analyzer for the measurement of whole-blood
composition97. The commercial microfluidic devices commonly require external
pressure source to drive fluid flow - as the power of the pump to drive fluid
31
3. ANALYTE DETECTION WITH ANTIBODY-CONJUGATED
MICROTUBULES IN GLIDING MOTILITY ASSAY
flow is inversely related to the volume of the fluid, this sets a practical limit on
miniaturization of these devices.
To overcome this limitation of miniaturization and develop portable point-
of-care devices working on very low sample volume, in vitro nanotechnological
applications of biomolecular motor based devices have been explored in recent
years. Biomolecular motors have evolved over millions of years to convert chemical
energy of ATP to mechanical work with incredible efficiency. Reconstitution of the
biomolecular motor based transport allows the fabrication of fast, miniaturized
detection devices that are driven by the active transport of biomolecular motors,
and therefore do not require any external pump to drive mass transport. In
this chapter, the antibody-conjugated microtubule platform developed in the
previous chapter (2) is used to develop biosensing applications. The first set
of applications focuses on the detection of protein analytes using fluorescence
microscopy. Thereafter, a label-free detection platform is developed that uses
supramolecular self-assembly of the antibody-conjugated microtubules as read-out
for analyte detection.
Publication Results from this chapter (section 3.2) have been submitted for
publication as:Label-free detection of microvesicles and proteins by the bundling of
gliding microtubules. Samata Chaudhuri, Till Korten, Slobodanka Korten, Gloria
Milani, Tobia Lana, Geertruy te Kronnie, and Stefan Diez. Nano Letters (in
review).
3.1 Fluorescence-based analyte detection
Development of analytical devices based on fluorescence offers several advantages,
such as, high-resolution data acquisition using relatively inexpensive set-ups,
availability of well-characterized fluorescent dyes, ability to provide information on
molecular interactions and conformational dynamics. Fluorescence-based detection
is therefore widely used in lab-on-chip biosensing devices.
A novel biosening platform was developed using the antibody-conjugated
microtubules (see Chapter 2) for the detection of fluorescent analyte. The platform
was then used for direct detection of fluorescent proteins (commercially available
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fluorescent secondary antibodies) and for detection of cell-lysate derived fusion
protein using a conventional double sandwich assay.
Detection of fluorescent protein analyte
Detection of fluorescent protein analyte was performed by using Ab-MTs in gliding
motility assays (Figure 3.1A). Fluorescent Alexa Fluor 488 anti-mouse secondary
antibodies were used as model protein analyte to specifically bind to the Ab-MTs.
Using Total Internal Reflection Fluorescence (TIRF) microscopy, the protein
analyte was found to specifically bind to - and to be transported by - the Ab-MTs.
After a short incubation incubation time of 10 min, it was possible to detect the
protein analyte at concentrations as low as 0.1 pM using microliter sample volumes
(Figure 3.1B). In the current assay setup, 0.1 pM of the analyte corresponds to
about 30,000 molecules in the volume of the flow channels, or an average of 3
molecules per field of view (about 80 µm × 80 µm). Analyte detection at this low
concentration demonstrates the high sensitivity of the detection method. Analyte
binding and transport was not observed with control microtubules that lacked the
covalently-conjugated antibodies on their surface, confirming the selectivity of the
method. Additionally, the sensitivity of the detection scheme was unaffected by
the presence of equivalent concentrations of fluorescent Cy3 anti-rabbit secondary
antibodies as background proteins (Figure 3.1C).
Detection of analyte by gliding Ab-MTs offers several advantages over methods
based on surface-immobilized antibodies: firstly, active transport allows distinction
of the specific transport of analyte bound to the gliding microtubules from back-
ground molecules unspecifically bound to the surfaces of the detection chambers.
Secondly, as active transport obviates elaborate washing steps, the detection time
can be significantly decreased and robust detection devices working with microliter
sample volumes can be fabricated.
Detection of abl-bcr fusion protein from leukemia cell lysate
Chronic myeloid leukemia (CML) is characterized by the presence of Philadelphia
chromosome, formed through reciprocal translocation of the ABL protocooncogene
from chromosome 9 to the BCR gene on chromosome 22 in leukemia cancer cells.
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Figure 3.1: Detection of fluorescent protein analyte using Ab-MTs. - (A)
Fluorescent protein analyte (Alexa Fluor 488 anti-mouse secondary antibodies)
was detected by Ab-MTs in gliding motility assays using TIRF microscopy. (B)
TIRF images of Ab-MTs (red) transporting fluorescent protein analyte (green)
at 0.1 pM, 1 pM, and 10 pM concentrations. Scale bar 5 µm. (C) Plotting the
increase in the fluorescence intensity of the analyte per unit length of Ab-MTs
as function of analyte concentration demonstrates the sensitivity of the detection
method down to 0.1 pM (red data). The sensitivity of the assay was not affected
by the presence of equal concentrations of background fluorescent protein analyte
(Cy3 anti-rabbit antibody; ‘BG protein’, blue line). Control microtubules without
conjugated antibodies showed no increase in the fluorescence intensity upon addition
of analyte (black line). For each data point, between 127 to 529 microtubules were
analyzed (mean ± standard deviation). The detected signal on AbMTs at 0.1 pM
analyte concentration was significantly different from that on the control MTs
(Mann-Whitney U = 0, p < 0.0001).
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The product of this fusion oncogene is a constitutively active tyrosine kinase (abl-
bcr fusion protein), that results in activation of several signaling pathways leading
to uncontrolled cellular proliferation and differentiation, and other characteristic
symptoms of CML. This characteristic genetic signature and the expression of the
abl-bcr fusion protein is a promising target for the development of diagnosis and
treatment of CML.
Figure 3.2: Schematic of reciprocal translocation in chronic myeloid
leukemia (CML) - Schematic showing the reciprocal translocation between chro-
mosome 9 and chromosome 22 resulting in the formation of an extra-long chro-
mosome (“der 9”) and the Philadelphia chromosome (Ph1). The product of this
Philadelphia chromosome is abl-bcr fusion protein, a biomarker for CML. Adapted
from www.biology-pages.info98
Currently, diagnosis of CML is carried out by bone marrow biopsy, qualita-
tive or quantitative PCR-based tests, and fluorescence in situ hybridization99.
However, due the asymptomatic nature of the disease, patients with CML are
mostly diagnosed at an advanced chronic stage of the disease in over 90% of the
cases. Despite the high success rate of the current treatments for CML, this
delayed diagnosis adversely affects on the prognosis and survival rates in patients.
Development of fast, sensitive, simple and portable detection platform is therefore
crucial for early diagnosis and treatment of CML.
As CML patients, even in the initial phase of the cancer, express the abl-bcr
fusion protein in the cells of their bone marrow as well as peripheral blood100,
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detection of this fusion protein can enable early diagnosis of the disease, as
well as assessment of the efficacy of various administered treatments. Here, a
biosensing platform based on antibody-conjugated microtubules is developed
for detection of abl-bcr fusion protein as a biomarker for CML diagnosis. The
detection platform was built using by adapting the basic assay set-up described
earlier 2.2. Anti-abl antibodies covalently conjugated to microtubules (Ab-MTs)
using tetrazine-trans-cyclooctene bioorthogonal chemistry constituted the detector
element. The following three cell lines were used for the experiments (Figure 3.3):
1. K652 Chronic Myeloid Leukemia cell line expressing CD45 surface antigen
and the abl-bcr fusion protein
2. DND41 Acute Lymphocytic Leukemia cell line expressing the CD45 surface
antigen but no fusion protein
3. MG63 Osteosarcoma cell line expressing neither the CD45 surface antigen
nor the fusion protein
K562 DND41 MG63
Type
Surface
Antigen
Fusion 
protein
CD45 + CD45 + CD45 +
Present Absent Absent
Chronic Myeloid 
Leukemia (CML)
Acute Lymphocytic 
Leukemia (CML)
Osteosarcoma
Figure 3.3: The cell lines used - K562, DND41, MG63
The cells from the above cell lines (Figure 3.3) were lysed, and the lysate added
to antibody conjugated microtubules in gliding motility assay. Figure 3.4 shows
the scheme of the detection assay. The detection platform consisted of anti-abl
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goat IgG antibodies covalently conjugated to the microtubules (Abl-MTs) using
trans-cyclooctene tetrazine bioorthogonal reaction. The abl-bcr fusion protein
from the cell lysate would bind via the abl-binding site to the antibody conjugated
microtubules. The detection of this fusion protein will be achieved using a double
sandwich assay scheme, where monoclonal anti-bcr sheep IgG antibodies would
bind to the bcr-moiety of the fusion protein, which would then be detected using
fluorescent anti-sheep secondary antibodies.
Culture Cell 
Lyse Cell 
1.+ Lysate
2. + Anti-bcr Ab
(sheep IgG) 
3. + Alexa488 
anti-sheep Ab
Abl-conjugated 
microtubule
Binding of abl-bcr 
fusion protein
Detection
Figure 3.4: Abl-bcr fusion protein detection scheme 1. - The cell lysate
was added to anti-abl antibody conjugated microtubules in a kinesin gliding motility
assay. Successful capture of abl-bcr fusion protein from the cell lysate is confirmed
by addition of monoclonal sheep IgG anti-bcr antibodies, followed by addition of
fluorescent Alexa Fluor 488 anti-sheep secondary antibodies
Control experiment was first performed by adding the secondary anti-sheep
antibodies to the Abl-MTs (anti abl antibody = goat IgG). The fluorescent anti-
sheep secondary antibody was found to cross react with the monoclonal goat
IgG on the microtubules, leading to a false positive in the absence of any fusion
protein. As a result, this scheme was rendered unsuitable for detection of the
abl-bcr fusion protein (Figure 3.5).
A modified approach was adopted for detection of the fusion protein. Here,
instead of using a double-sandwich type of assay with fluorescent secondary
antibodies, a direct detection scheme with fluorescently labeled antibody was
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+ Alexa488 
anti-sheep Ab
Figure 3.5: Control experiment with detection scheme 1 - Addition of
Alexa Fluor 488 anti-sheep secondary antibodies to gliding abl(goat IgG)-conjugated
microtubules led to bundling of the microtubules due to cross-reactivity of the
anti-sheep secondary antibodies with the goat IgG antibodies on the microtubules.
Scale bar 5 µm.
employed. The fusion protein from the cell lysate would bind to the Abl-MTs via
the abl-fragment, and then be detected with fluorescent Alexa Fluor 488 labeled
anti-bcr antibodies in the gliding motility assay.
1.+ Lysate
2. + Alexa488 
anti-bcr Ab
Abl-conjugated 
microtubule
Binding of abl-bcr 
fusion protein
Detection
Figure 3.6: Abl-bcr fusion protein detection scheme 2 - Scheme - 1 (3.4)
was modified to use fluorescent Alexa Fluor 488 anti-bcr antibodies for detection of
the fusion protein in the second step
The cell lysate was obtained from the with 7000 cells/µl of the K562 (CML)
cells and the DND41 (ALL, control) cells. Addition of the cell lysate led to
decline in the gliding velocity of the microtubule as well as considerable micro-
tubule bundling. The number of cells in the lysate was therefore diluted to
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prepare lysate using 700 cell. At this concentration, the microtubule retained
their normal motility. This observation is in line with the findings of Korten
et al. 101 , who reported that cell lysate obtained from a large number of cells
(10000 cells/µl reported value) led to slow-down of the filaments and filament
bundling for kinesin-microtubule gliding motility assays.
Before After addition of cell lysate 
from 7000 cells/μl from 700 cells/μl
Figure 3.7: Effect of cell lysates on gliding microtubules. - Fluorescence
images showing the abl-conjugated microtubules (magenta) before (left image) and
after (middle and right image) addition of the cell lysate from K562 leukemia cells,
followed by addition of Alexa Fluor 488 anti-bcr antibodies (cyan). The addition
of cell lysate obtained from 7000 cells/µl led to microtubule aggregation (middle
image), while the lysate obtained from 700 cells/µl did not affect the microtubule
motility (right image). Scale bar 5 µm.
Following the addition of cell lysate from 700 cells/µl of K562, DND41 and
MG63 cells to the Abl-MTs and subsequent addition of Alexa Fluor 488 anti-
bcr antibodies, the fluorescence signal from the anti-bcr antibodies on the Abl-
MTs was quantified. Figure 3.8 shows the fluorescence signal (per unit length
of microtubule) from the anti-bcr antibodies on the Abl-MTs and the control
microtubules (Ctrl-MT, without any antibody conjugated to the surface) after the
addition, incubation, and washing off the cell-lysate from the three cell lines. The
fluorescence intensity due the the K562 cell lysate was found to be significantly
higher than that observed on addition of the cell lysate from either the MG63 or
the DND41 cells. The fluorescence intensity due to the MG63 and DND41 cell
lysate was comparable to that observed due to binding of the Alexa Fluor 488
anti-bcr antibodies in the absence of any cell lysate. A cut-off value set using
the mean intensity ± 5 × standard deviation due to the negative control (no
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cell lysate, only Alexa Fluor 488 anti-bcr antibodies added to gliding Abl-MTs)
allowed clear distinction of signal due to the K562 lysate from that due to the
control MG63 and DND41 cell lysates.
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Figure 3.8: Detection of fusion protein from Chronic Myeloid Leukemia
(CML) Cell line. - The fusion protein was detected by quantifying the fluorescence
signal per unit length of the microtubules from the Alexa Fluor 488 anti-bcr
antibodies using TIRF microscopy. The blue bars corresponds to the signal detected
from the control microtubules, while the red bars indicate the signal detected from
the Abl-MTs. The dotted line corresponds to mean ± standard deviation from the
negative control (no cell lysate, only Alexa Fluor 488 anti-bcr antibodies added to
the gliding Abl-MTs). Addition of cell lysate from the K652 CML cell line results
in significant increase in signal, observed from both the Abl-MTs as well as the
control microtubules.
Interestingly, both the Abl-MT as well as the control-microtubules displayed
similar increase in the fluorescence signal on addition of the K562 cell lysate.
This indicates that while the fusion protein binds to the Abl-MTs, the control
microtubules also manage to capture the fusion protein or some other component
from the lysate that is later recognized by the anti-bcr antibodies. Following up
on this perplexing result led to a previous work by Miroshnychenko et al. 102 , who
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showed that pleckstrin homology domain from abl-bcr fusion protein has a very
specific and high binding affinity to β tubulin. This study provides an explanation
for the result obtained - the fusion protein binds to the anti-abl antibodies on
the Abl-MTs, as well as to the β tubulin of the control microtubules, and is
later recognized and quantified by the Alexa Fluor 488 anti-bcr antibody. This
serendipitious result underscores the potential application of a standard gliding
motility assay for the detection of abl-bcr for the diagnosis of CML.
3.2 Label-free analyte detection
Analyte detection is crucial for applications in healthcare103,104, environmental
and food safety105, and drug discovery106. Thereby, the development of fast
and sensitive label-free detection methods is becoming increasingly important as
analyte labeling, besides being labor-intensive, expensive and time-consuming,
often compromises the results107,108. Label-free detection contributes to fidelity and
robustness of the assay. However, so far, most of the available label-free detection
methods are based on surface reactions, often lacking the desired sensitivity and
speed109,110.
To overcome these limitations, a label-free detection platform was developed
based on the self-assembly of antibody-conjugated microtubules (Ab-MTs) in a
kinesin gliding motility assay. Owing to their small size, energy efficiency, and
robustness in synthetic environments, biomolecular motors (like kinesin) and their
associated cytoskeletal filaments (like microtubules) are an attractive choice for a
wide range of nanotechnological applications45,79–81. Over the past decades, the
biomolecular motors and their associated filaments have been extensively used
for developing molecular sorting3,7,9,11,111, surface imaging44, and biosensing6,10,87
devices. Around the same time, considerable research has been focused on studying
the dynamic self-assembly (bundling and spooling) of cytoskeletal filaments, driven
by active transport of biomolecular motors, that leads to the formation of highly
ordered supramolecular structures in vitro 48,49. While these latter studies aimed
at understanding and tuning the mechanism of biomolecular motor driven self-
assembly process112–115, engineering applications with this phenomenon has not
yet been reported.
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+ Analyte
Ab-MTs gliding on Kinesin-1 
coated glass surface
Analyte binds to antibodies 
on gliding Ab-MTs
Ab-MTs cross-link via bound 
analyte
Bundling of Ab-MTs 
Figure 3.9: Scheme showing label-free detection of multivalent analyte. -
Antibody conjugated microtubules (Ab-MTs) assemble to supramolecular assemblies
of bundles and spools due to binding of the multivalent analyte.
Here, the Ab-MTs gliding over surface immobilized kinesin motors were used
for the label-free detection of multivalent analytes (Figure 1). The antibodies on
the gliding Ab-MTs capture the analyte by binding to their antigenic sites. For a
multivalent analyte, each analyte molecule can bind to multiple Ab-MTs, thereby
cross-linking them. In a motor-driven gliding motility assay, this results in the
formation of supramolecular bundles and spools of Ab-MTs. This behavior of
the gliding Ab-MTs upon addition of multivalent analytes enables the label-free
detection of the analyte through characterization of Ab-MT bundling. Utilizing
this phenomenon. the label-free detection of microvesicles and multivalent proteins
was demonstrated, and the cross-reactivity between secondary antibodies was
profiled. This reported method combines the inherent advantages of biomolecular
motors for nanoscale transport with the motor-driven self-assembly of cytoskeletal
filaments to successfully engineer a label-free biosensor for analyte detection.
Label-free detection of microvesicles as biomarker for acute
lymphocytic leukemia
Microvesicles (MVs) are membrane-bound sacs with size of 50 nm to 1000 nm
shed from almost all cells. The MVs reflect the antigenic and molecular content
of the cells of origin, with a vital role in cell-to-cell communication as vehicles of
biological information between cells under both normal and pathological condi-
tions116,117. In recent years, there has been a growing interest in characterizing
MVs as biomarker for various diseases and developing diagnostic devices based
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on MV detection118–120. However, successful detection and development of effec-
tive diagnostic platforms with MVs remain challenging due to the requirements
of extensive sample preparation and labeling steps118,121. To overcome these
challenges, a biomolecular motor based MV detection platform was developed
by using Ab-MTs in a gliding motility assay. As models, two different human
cell lines were used – an acute lymphocytic leukemia (ALL) patient-derived hu-
man T-cell line (DND41, leukemia cell line) and a human osteosarcoma cell line
(MG63, control cell line). The leukemia cells have hematopoietic marker CD45
antigens on their surface, while the control osteosarcoma cells lack these surface
antigens120. Consequently, the leukemia cells and the control cells release CD45+
MVs (leukemia-MVs) and CD45- MVs (control-MVs), respectively.
MVs were isolated from 1000 cells/µl of the leukemia and the control cells
(method detailed in section 6.4). A schematic of the assay is shown in Figure
3.10A. On addition of the leukemia MVs, the gliding Ab-MTs slowed down,
and on encountering other Ab-MTs, assembled into bundles and spools, which
continued adding more Ab-MTs units, propagating the dynamic self-assembly
process. Fluorescent labeling of the cell lines prior to MV isolation yielded
fluorescently labeled MVs, and the fluorescent signal from leukemia MVs was
found to colocalize with that from the supramolecular Ab-MT assemblies. Control
microtubules without antibodies conjugated to their surface showed no such self-
assembly phenomenon on addition of the leukemia MVs and continued gliding
without any change in their velocity. Additionally, no change in Ab-MT gliding
was observed on addition of the control MVs, which did not show any colocalization
with the Ab-MT either, confirming the specificity of the detection method (Figure
3.10B).
As the single Ab-MTs assembled into bundles on addition of the leukemia MVs,
there was a corresponding increase in fluorescence intensity. Thus, by monitoring
this increase in fluorescence intensity of the Ab-MTs, microtubule bundling due
to the added analyte could be followed. The bundling process was quantified by
monitoring the increase in fluorescence intensity of the Ab-MT assemblies. Median
of the top 1% of the Ab-MT intensities (referred to from now on as fluorescence
intensity or F.I.) in the field-of-view (FOV) was measured for several FOVs (30-40
FOVs) for 30 min after addition of the analyte. As the analyte causes the single
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Figure 3.10: Label-free detection of microvesicles (MVs) as biomarker
for acute lymphocytic leukemia (ALL). - (A) Schematic showing the workflow
of MV detection. Leukemia MVs and control MVs were isolated by serial centrifu-
gation from the supernatant of the cell culture of acute lymphocytic leukemia cells
and osteosarcoma cells. The purified MVs were added directly to a gliding motility
assay consisting of Ab-MTs and control MTs. The leukemia MVs cross-link the
gliding Ab-MTs, causing the latter to bundle into supramolecular assemblies. This
characteristic bundle and spool formation of the Ab-MTs on analyte addition is used
as read-out for label-free analyte detection. (B) Fluorescence images of rhodamine
labeled Ab-MTs (red) and Cy5-labeled control MTs (cyan) after addition of the
labeled MVs (green). Addition of control MVs to assay does not affect the gliding
of either the Ab-MTs or the control MTs. Addition of the leukemia MVs lead to the
formation of large supramolecular assemblies of Ab-MT bundles and spools. This
bundling process due to the leukemia MVs is specific; the control MTs continue
gliding unaffected in the presence of the MVs. Fluorescent labeling of the cell lines
prior to MV isolation yielded fluorescently labeled MVs. Exclusive co-localization
of the fluorescence signal from the leukemia MVs to the Ab-MTs, and not the
control-MTs further confirm the specificity of the detection. Scale bar 20 µm. (C)
Plot of normalized F.I. of the Ab-MTs with time on addition of the leukemia MVs
(green line) and the control MVs (purple line) shows characteristic increase in F.I.
only for the leukemia curve.
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Ab-MTs to assemble to bundles, the intensity histogram of the fluorescent Ab-MTs
shifts towards a higher value. A plot of normalized F.I. versus time of the Ab-MTs
after addition of the leukemia MVs and control MVs is shown in Figure 3.10C.
While there was no change in the F.I. values of the Ab-MTs on addition of the
control MVs, that of the Ab-MTs rapidly increase on addition of the leukemia
MVs and eventually plateaus off. This distinct bundling profile of the Ab-MTs
was used as read-out for the detection of the analyte. As the detection method is
based on quantification of the signal from the self-assembly of Ab-MTs, it obviates
the need to label the analyte, allowing label-free detection of the latter.
This example demonstrates the proof-of-principle application of the detec-
tion platform in future lab-on-chip devices for leukemia diagnosis. The method
circumvents the need to label the isolated MVs, overcoming a key setback in
development of MV based detection methods. Moreover, as the detection principle
is based on molecular recognition between antigen and antibody, the biosensing
platform can be easily adapted for MV-based diagnostic assessment of other
medical conditions. The portability and ease of detection with the method is
promising for the development of future, point-of-care MV detection.
Label-free, sub-nanomolar protein detection using the Ab-
MT bundling as read-out
Dynamic self-assembly of gliding microtubules has been described earlier with
biotinylated microtubules cross-linked by streptavidin48,49. Here we show that
such self assembly process can also be brought about by any multivalent entity
that can bind to specific sites (e.g. biotin or antibody) on the MTs. To explore
further applications based on this phenomenon, the Ab-MT biosensing platform
was used for label-free detection of proteins.
Alexa Fluor 488 anti-mouse secondary antibodies were used as model protein
analyte to bind specifically to the mouse IgG antibodies on the surface of the Ab-
MTs. Addition of the protein analyte led to similar read out as on addition of the
leukemia MVs, i.e. rapid decline in gliding velocity and formation of characteristic
large supramolecular assemblies of Ab-MT bundles. Control microtubules without
antibodies conjugated to their surface showed no such self-assembly phenomena
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Figure 3.11: Label-free protein detection and profiling of antibody cross-
reactivity - (A) Fluorescent images of Ab-MTs and control-MTs before and after
addition of 10 nM model protein analyte. Addition of the specific protein analyte
led to bundling and spooling of the Ab-MTs, but not of the control MTs. As the
analyte used here was fluorescent Alexa Fluor 488 anti-mouse secondary antibody,
exclusive co-localization of the fluorescent signal from the analyte to the Ab-MT
assemblies confirms the specificity of the detection method. Scale bar 5 µm. (B)
Fluorescence images of rhodamine labeled Ab-MTs in kinesin gliding motility assay
before and after addition of the model protein analyte. The characteristic bundle
and spool formation of the Ab-MTs on addition of the analyte was observed from 10
nM to 0.1 nM analyte concentrations. Scale bar 5 µm. (C) Plot of normalized F.I
versus time for the Ab-MTs after addition of different concentration of the protein
analyte. By fitting a second order polynomial to the curve obtained, the rate of
bundling of the Ab-MTs was estimated from the slope of the curve at t = 0 for the
protein analyte concentration of 10 nM, 1 nM and 0.1 nM (D) The rate of bundling
for various concentrations of the protein analyte. (E) The reciprocal plot of the
rate of Ab-MT bundling versus analyte concentration shows a linear dependence.
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on addition of the analyte and continued gliding without any change in their
velocity. As the analyte used here was fluorescent as well, observation of specific
co-localization of the signal from the analyte to the Ab-MTs, and not to the
control microtubules confirms the specificity of the detection method (Figure
3.11A).
Next, the sensitivity of label-free protein detection with the Ab-MT biosensors
was investigated. Rapid and specific bundling of Ab-MTs was observed on analyte
addition over a wide range of concentrations (Figure 3.11B). By quantifying
the rate of increase in F.I. as a measure of the rate of Ab-MT bundling, the
concentration of the added analyte could be determined (Figures 3.11C-E). The
distinct bundling profile of the various analyte concentrations tested allows the
label-free protein detection method to be quantitative, with sensitivity down to
0.1 nM concentration.
Thus, a simple, fast and robust method for label-free protein detection with
sub-nanomolar sensitivity was successfully developed. The versatility of the
method lies in the fact that by changing the antibody conjugated to the surface of
the Ab-MT biosensing element, the platform can be easily adapted for detection
of a wide range of analyte.
Profiling antibody cross-reactivity
Antibodies recognize and bind to specific regions on the antigen surface called
epitope. However, in practice, antibodies can bind to similar sequence present on
other antigens, leading to undesired cross-reactivity. Despite the widespread use
of antibodies in biological research, diagnostics and therapeutics, cross-reactivity
of antibodies poses a serious problem122. Evaluation of antibody cross reactivity
is therefore crucial for any antibody-based application.
Here, cross reactivity between various secondary antibodies to monoclonal
mouse antibody (human anti-CD45 mouse IgG antibody) present on the surface
of the Ab-MTs was investigated. Secondary antibodies are commonly used in
biochemical assays like Western blotting, flow cytometry, immunohistochemistry,
and cross reactivity between secondary antibodies can compromise the assay
results. The following commercially available secondary antibodies were tested
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Figure 3.12: Profiling antibody cross reactivity. - (A) Fluorescent images of
rhodamine labeled Ab-MTs before and after addition of 10 nM of various secondary
antibodies (anti-mouse, anti-rat, anti-rabbit and anti-sheep secondary antibodies).
Addition of anti-mouse secondary antibodies led to the characteristic bundling
of the Ab-MTs, which have monoclonal mouse IgG on their surface. However,
cross-reactivity between anti-rat secondary antibodies and mouse IgG on Ab-MTs
also led to the formation of bundles and spools of Ab-MTs. No cross-reactivity
between anti-rabbit and anti-sheep secondary antibodies was observed with the
mouse IgG on the Ab-MTs. Scale bar 5 µm. (B) The cross-reactivity between
various secondary antibodies with mouse IgG on the Ab-MTs can be estimated by
plotting the normalized F.I. of the Ab-MTs with time. By obtaining the rate of
bundling of the Ab-MTs due to the secondary antibody, the secondary antibody
cross reactivity can be estimated.
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for their propensity to bind to mouse monoclonal antibody: anti-mouse, anti-rat,
anti-goat and anti-sheep antibodies.
Each of the secondary antibodies at 10 nM concentration was added to the Ab-
MTs in kinesin gliding motility assay (Figure 3.12A). Addition of the anti-mouse
secondary antibodies led to rapid bundling of the Ab-MTs, as expected. Addition
of 10 nM of anti-rat secondary antibodies also led to Ab-MT self-assembly and
bundling; no such self-assembly process was observed on addition of anti-goat or
anti-sheep secondary antibodies at the same concentration. By quantifying the rate
of Ab-MT bundling, the extent of cross-reactivity of these secondary antibodies
with monoclonal mouse antibodies could be estimated (Figure 3.12B). The rate of
bundling was found to be 0.0630 ± 0.0036 min−1 and 0.0371 ± 0.0031 min−1 with
10 nM anti-mouse and anti-rat antibodies respectively, while no bundling was
observed for the anti-goat and anti-sheep antibodies. Given the closeness at species
level between mouse and rat, the degree of cross-reactivity of anti-rat secondary
antibodies to mouse IgG antibodies can be explained. Thus, using bundling of
Ab-MTs as a read-out, successful application of the developed biosensing platform
was demonstrated as a tool for rapid profiling of antibody cross reactivity.
3.3 Conclusion
In this chapter, a biosensing platform for analyte detection was developed by cova-
lently conjugating antibodies to microtubule using the tetrazine-trans-cyclooctene
iEDDA reaction established previously in chapter 2. Two types of analyte-detection
schemes were employed - fluorescence-based analyte detection and label-free ana-
lyte detection. In the first scheme, highly sensitive, sub-picomolar detection of
fluorescent protein was demonstrated with the gliding antibody-conjugated micro-
tubules. Next, a label-free detection method was demonstrated by quantifying the
read-out of microtubule bundling in the presence of specific analyte. The label-free
detection platform was used to specifically detect microvesicles as biomarkers
for leukemia diagnosis. Additionally, the versatility of the label-free method
was demonstrated by profiling cross-reactivity between commercially available
secondary antibodies. Since the biorecognition principle of the developed detection
platform is based on molecular recognition between antigen and antibody, the
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assay is easily amenable to be used for the detection of a wide range of analytes
with known and available antibodies or other capture agents such as aptamers.
With the variety of commercially available antibodies and the ongoing research on
identifying microvesicles for cancer diagnosis, the reported method paves way for
the development of fast and sensitive detection platform for point-of-care diagnosis
of various diseases.
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Microtubule gliding in
nanostructures
An important criterion for efficient transport is successful control over the trans-
port directionality. Although in vitro reconstitution microtubule transport by
biomolecular motors have been established in the last few decades, the field of
nanotechnological applications of biomolecular motors still faces the challenge of
achieving controlled, unidirectional transport. As most of the nanotechnological
applications employ the gliding motility assay geometry, considerable research
effort has been directed over the years at controlling the microtubule gliding motil-
ity, such as by using chemical pattering or topographical structures (detailed in
the section 1.2). A combination of both these methods, where the motor proteins
are specifically restricted through differential surface chemistry to the bottom of
trenches in topographical structures, has proven to be most successful9,72,77,123,124.
The ease of fabrication and design flexibility offered by the topographical
structures has led to the development of several applications including fabrication
of molecular sorting devices for protein concentration9,74, and parallel biocom-
putation network based on lithographic patterning124. While the lithographic
microstructures provide a promising means of controlling microtubule motility
through physical confinement, robust assay performance in these surfaces is critical
for the development of more challenging applications with biomolecular motors.
Low quality of gliding motility assay on these structures due to reduced micro-
tubule landing, increased microtubule detachment, and frequent impairment of
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motility due to stuck microtubules currently limits the practical applicability of
these structures66,69,74.
Previous studies have focused on understanding how the structural design of
the nanostructures affect the quality of microtubule motility. While these studies
led to the design of structures with improved microtubule guiding, all these studies
employed the standard gliding motility assay as used on glass surface, and do not
address the issues arising out of variability in the basic assay set-up. To further
implementation of these structures, it is important to understand how the basic
assay components, such as the type of kinesin or microtubule stabilization method
affects the assay performance.
Here, gliding motility under different assay conditions on the nanofabricated
chips will be characterized to develop an optimized assay protocol for improved
gliding motility assay on these lithographic nanostructures. Following the op-
timization of assay protocol for the nanostructures, a lab-on-chip concentrator
device to effectively guide and direct the microtubule motility is developed. Based
on previous design of lithographically patterned structures to rectify and control
microtubule motility in vitro 123, the nanostructured device aims at achieving a
concentration effect that can improve the detection limit in microtubule-motor
based biosensing applications. The efficiency of this concentrator effect is evaluated
and a potential application demonstrated using leukemia-cell derived microvesicle
transport and concentration in the devices.
Publication Results from this chapter (section 4.1) have been included in:
Kinesin-1 expressed in insect-cells improves microtubule in vitro gliding perfor-
mance, long-term stability and guiding efficiency in nanostructures. T. Korten, S.
Chaudhuri, E. Tavkin, M. Braun, and S. Diez. IEEE Transactions on NanoBio-
science, 15(1), 62-69 (2016).
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4.1 Characterization of microtubule gliding in
nanostructures
A combination of nanofabrication process and chemical adsorption, similar to the
one described earlier123, was used to design the chips (details of the fabrication
process in section 6.5). The structures consisted of a gold (Au) floor surrounded by
500 nm high glass boundary walls. The glass walls were coated with PEG-silane,
followed by kinesin immobilization on the gold surface. This restricted microtubule
motility only on the Au surface, with the delineating PEGylated walls acting as
physical confinements guiding the microtubule movement.
θ
Guided MT
Guided MT
MT approaching 
boundary wall 
Non-guided MT
Non-guided MT
10µm
0 s 6 s 12 s 18 s 24 s
Guided MT
(MT follow the boundary)
Non-guided MT
(MT detach at the boundary)
A
B
Figure 4.1: Microtubule guiding by the topographical structure. - A. The
gliding microtubules on reaching the PEGylated boundary wall can either be guided
to continue gliding in the Au channel (guided MT), or can escape the channel by
crossing the boundary or detaching (non-guided MT). B. Fluorescence images of
rhodamine labeled microtubules being guided (top row), or detaching (bottom row)
on approaching the boundary wall.
Microtubule gliding was restricted only to the gold surface, with no gliding
observed on the glass surfaces. This can be attributed to the protein-repellant
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PEG coating of the glass surfaces, which prevent the binding of kinesin and
subsequent motility of the microtubules.
To characterize motility on the nanostructures, the efficiency of guiding the
microtubules within the channel design was evaluated (Figure 4.1). The approach
angle, θ, of the microtubule was calculated relative to the boundary as shown in
Figure. An event was classified as a guiding event if the microtubule oriented
itself with the boundary wall and continued gliding within the channel. A non-
guiding event was defined when the microtubule approaching the boundary wall
detached from the surface, or climbed up the boundary wall to move into the
PEGylated region. The data was binned in histogram with 15° intervals. The
guiding efficiency was calculated as a ratio of guiding events to the total number
of events (guiding and non-guiding) for a given range of approach angles:
E =
Nguided
Ntot
(4.1)
where E is the guiding efficiency, Nguided is the number of microtubules guided
at the boundary wall, Ntotal is the total number of microtubules approaching the
boundary wall (guided microtubules and microtubules leaving the structure at
the wall).
Following the method used by Clemmens et al76, the standard error (SE) for
the guiding efficiency was calculated as:
SE =
√
E (1 − E)
Ntotal
(4.2)
Guiding efficiency was examined for gliding motility assay on rectangular
nanostructures. The following conditions were evaluated:
1. Attachment of kinesin motors on the surface by non-specific (adsorption on
casein) and specific (immobilization with antibodies) means
2. Kinesin-1 protein expressed in different systems (bacterial cells versus insect
cells)
3. In vitro microtubule polymerization and stabilization methods
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Kinesin motors non-specifically adsorbed on casein coated
surface efficiently guides the gliding microtubules in nanos-
tructures
For these experiments, recombinant (expressed in E.coli) kinesin consisting of
full length D. melanogaster kinesin-1 heavy chain, flanked with a C-terminal
histidine-tag was used23.
Kinesin
Casein
Anti-his antibody
Casein Assay
A
B
Antibody Assay
Figure 4.2: Guiding efficiency in casein assay and antibody assay. - A.
Schematic showing the setups for the antibody gliding motility assay (Antibody
Assay, left) and the casein gliding motility assay (Casein Assay, right). B. Angle
dependence of guiding efficiency for the two assay setups (mean ± standard error).
The magenta bars represent the guiding efficiencies for the casein assay, while the
cyan bars represent that for the antibody assay.
In a gliding motility assay, the kinesin proteins can be immobilized on the
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surface either through non-specific surface absorption on a layer of casein (Casein
assay), or through specific attachment to surface immobilized anti-his antibodies
(Antibody assay). The assay schemes are shown in Figure 4.2A. The efficiency
of guiding microtubules in the nanostructures was compared between the casein
assay and the antibody assay setups.
Figure 4.2B shows the angle dependence of guiding efficiency of microtubules
approaching a boundary wall for the casein assay (magenta) and antibody assay
(cyan). A decrease in guiding efficiency with increasing approach angle of micro-
tubule at the boundary wall was observed for both the assay setups. For small
approach angles (upto 30°), the guiding efficiency was 100% in both the assays,
implying that all microtubules approaching the boundary wall at these angles
continued to follow the wall and be guided within the channels. At higher approach
angle, the casein assay achieved relatively better microtubule guiding efficiency
compared to the antibody assay. The overall average guiding efficiencies were
70.3 ± 5.0 % and 61.2 ± 7.9 % for the casein assay and antibody assay respectively.
The casein gliding motility assay with bacterial expressed kinesin thus exhibited
relatively improved performance compared to the antibody gliding assay on the
nanostructures.
Kinesin motors expressed in insect cells improves guiding
efficiency in nanostructures
Traditionally, the kinesin motors used for nanotechnological applications are
purified in vitro using a bacterial expression system23. Recently, an insect cell
expression system for his-tagged kinesin construct from D. melanogaster was
developed in the lab. As the insect cell expression provides more conducive
environment (eukaryotic chaperons and post-translational machinery) for the
protein, the insect-cell expressed kinesin was found to show higher purity and
improved activity compared to the same protein sequence expressed in bacteria125.
Here, the guiding efficiency of gliding microtubules in nanofabricated structures
was evaluated with the kinesin purified from the two expression systems - bacterial
expression system and insect expression system. A casein gliding motility assay
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setup (that demonstrated better gliding than the antibody assy setup, see 4.1)
was used for to compare the effect of the two kinesins.
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Figure 4.3: Guiding efficiency for casein gliding motility assay with
insect-cell expressed kinesin and bacterial expressed kinesin. - Angle
dependence of guiding efficiency for the casein gliding motility assay set-up with two
different kinesins (mean ± standard error). The blue bars represent the insect-cell
expressed kinesin, while the magenta bar corresponds to the bacteria-expressed
kinesin
Figure 4.3 shows the angle dependence of guiding efficiency of microtubules
approaching a boundary wall for the kinesin expressed in insect cells (blue) and
kinesin expressed in bacterial cells (magenta). For both the kinesin expressions,
microtubules were successfully guided for when they approached the boundary
wall at angles below 30°. For kinesin expressed in bacteria, the guiding efficiency
dropped to almost 50 % at approach angles higher than 45°. On the other hand,
for kinesin expressed in insect cells, high guiding efficiencies (close to 100 %) was
observed for approach angles as high as 75°. Even at higher angles (75–90°), the
guiding efficiency was observed to be around 83 %. The overall average guiding
efficiencies were 70.3 ± 4.9 % and 95.5 ± 1.2 % for kinesin expressed in bacteria
and kinesin expressed in insect cells, respectively. Except for very specific design
geometries75,78, the remarkably high guiding efficiency observed for insect-cell
expressed kinesin is higher than almost all of the previously reported microtubule
guiding efficiencies72,77,123. This demonstrates that kinesin expressed in eukaryotic
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expression system of insect cell exhibit superior performance compared to kinesin
expressed in prokaryotic bacterial expression system.
Lower flexural rigidity of microtubules improves guiding
efficiency in nanostructures
Microtubules are the stiffest intracellular cytoskeletal filaments126. Several stud-
ies have shown that the stiffness of the microtubules can be tuned by varying
the nucleotide used to polymerize microtubule and by changing the stabilizing
agent used to prevent depolymerization of the microtubules59,127–129. The most
common method of preparing microtubules in vitro involves polymerizing tubu-
lin with GTP, followed by stabilization with taxol. Microtubules prepared by
this method has been shown to have flexural rigidity of 2.5 ± 0.5 × 1024 Nm2 129.
Alternatively, microtubules can be polymerized using the slowly hydrolyzable
nucleotide analogue – GMPCPP. This results in stiffer microtubules, with flexural
rigidity of 8 ± 2 × 1024 Nm2 129. A third method of preparing microtubule that
greatly enhances their long-term stability of the microtubules involves microtu-
bule polymerization with GMPCPP, followed by stabilization with taxol. These
“double-stabilized” microtubules have a flexural rigidity of 8 ± 3 × 1024 Nm2 129,
similar to that of the GMPCPP polymerized microtubules.
While long-term stability of microtubules is desirable for several nanotechno-
logical applications, it is important to gain a wholesome understanding of how
the stiffness of the microtubules affect the performance of gliding microtubules
in nanostructured devices. To investigate that, guiding efficiency of gliding mi-
crotubules was evaluated for the three methods of microtubule preparation, in a
casein gliding motility assay with insect-cell expressed kinesin motors.
Figure 4.4 shows the angle dependence of guiding efficiency of microtubules
approaching a boundary wall for the following microtubule preparations: GTP
polymerized microtubules stabilized with Taxol (GTP-Taxol, blue), GMP-CPP
polymerized microtubules (CPP, magenta), and GMP-CPP polymerized micro-
tubules stabilized with Taxol (CPP-Taxol, cyan). The flexible GTP-Taxol mi-
crotubules were found to have an almost 100 % guiding efficiency upto a high
approach angle of 60◦. Even at higher approach angles (75-90◦), the GTP-Taxol
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Figure 4.4: Guiding efficiency for various microtubules in a casein gliding
motility assay. - Angle dependence of guiding efficiencies (mean ± standard error)
for the flexible GTP-Taxol microtubules (dark blue bars), and the stiff GMP-CPP
stabilized microtubules (magenta bars) and the GMP-CPP and taxol stabilized
microtubules (cyan bars).
microtubules continued to be efficiently guided after encountering a boundary
wall. In contrast, the stiffer CPP microtubules and the CPP-Taxol microtubules
showed lowered guiding efficiencies at high angles of approach. The performance
of the CPP-Taxol microtubules was found to be the worst at higher approach
angles (75-90◦). The overall guiding efficiencies were found to be 95.5 ± 1.2 %,
85.2 ± 5.8 %, and 74.3 ± 9.1 % for the GTP-Taxol, CPP, and CPP-Taxol micro-
tubules respectively. Thus, the most flexible GTP-Taxol microtubules achieved
the highest guiding efficiency on nanostructures in a casein gliding motility assay
with insect-cell expressed kinesin.
4.2 Concentrator device
Development of ultrasensitive biosensors is crucial for viable point-of-care diag-
nostic applications. The concentration of biomarkers in clinical samples often
fall in the nM range and lower, necessitating the concentration of samples by
centrifugation and other methods before analysis to be in the dynamic detection
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range of the employed techniques. These pre-processing steps limits the applica-
tion of the existing detection methods in a high-throughput, point-of-care setting.
While the kinesin-microtubule system has been extensively used to demonstrate
proof-of-principle biosensing and analyte detection applications, improvement in
detection limit is required for translation of these applications to a practical clinical
setting. Here, the nanostructures, that are used to spatially control directionality
of the gliding microtubules, are used to achieve analyte concentration as well, by
transporting them from a larger loading region to a smaller detection region, to
improve detection.
The concentrator device design is shown in Figure 4.5. The flower-shaped
design guides the microtubule movement from the wider petal-shaped regions
to the circular center, effectively concentrating the microtubules to the center.
Analyte bound to the microtubules will also be transported to the center and get
concentrated in the process (analyte from a larger region will now be restricted to
a smaller region thereby concentrating them), improving the detection limit.
Efficiency of the concentrator device
Different designs of the concentrator device were evaluated for microtubule con-
centration efficiency. The flower-shaped structures consisted of either 8 or 10
petals, with three different diameters of the central disk (30 µm, 45 µm, 60 µm).
The efficiency of each of the design was evaluated with concentration factor that
calculates the relative increase in intensity (of the microtubules) at the center.
As the fluorescent microtubules move from the petals to the central circle, there
is a corresponding decrease in fluorescence intensity in the petals, and an increase
in fluorescence intensity at the center. By manually defining a circle corresponding
to the central disk of the device, the observed increase in mean intensity with time
was measured (Figure 4.6) to evaluate the concentration factor. For the designs
evaluated, the concentration factor was found to increase with time roughly for the
first 3 min (imaging started immediately after adding the microtubule solution),
but declined thereafter in almost all cases. This happens because in this time
frame, the central region of the nanostructures gets saturated with microtubules,
and therefore, any additional microtubule trying to get “concentrated” to this
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Figure 4.5: Concentrator device. - A. The design of concentrator device.
The flower-shaped device consists of multiple petal-shaped loading regions that
spatio-temporally concentrate the gliding microtubules to the central concentrating
region (Image courtesy: Till Korten). B. Fluorescence images of rhodamine labeled
microtubules concentrated to the centre of the concentrator device with time. Scale
bar 25 µm
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Figure 4.6: Efficiency of the concentrator device. - Concentration efficiency
was evaluated for various device design. Each of the identically-processed devices
consisted of 8 or 12 petals, with different diameter of the cental circle. The number
of petals (P) and the diameter of the circle (C, in µm ) are indicated in the
graph legend as P-C. A. Fluorescence image of rhodamine labeled microtubules
concentrated at the center of the device. The increase in fluorescence intensity with
time is followed for the central region (yellow circle demarcating the center) to
quantify the concentration factor. B. As the microtubules are concentrated mostly
in a ring-shaped region along the periphery of the central region, the increase in
fluorescence intensity with time is monitored for this ring-shaped region (yellow
circles, left image) to quantify the concentration factor. Scale bar 25 µm
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already-microtubule crowded region gets detached from the nanostructure surface,
lowering the concentration factor at later times.
Also, it was observed that the concentrated microtubules were restricted only
to the periphery of the central region, and were gliding in a ring shaped region
along the circumference. Therefore, a second evaluation method was employed,
where a ring shaped region was defined as the concentrator region, and instead of
observing the intensity change in the whole central disk, intensity change due to
concentration of the microtubules was evaluated only for this ring-shaped region
(Figure 4.6). The concentration factor was found to be relatively higher in this
case, reaching almost twice the initial intensity within the first 3-5 min for most
device designs. The decline in the concentration factor was observed after the
first 3-5 min, similar to the previous evaluation.
The overall concentration factor (for the first 5 min) ranged from about 1.5
to almost 3. A high variability in the concentration factor was observed, even
between identical device designs. The performance of the 12 petal designs was
usually better than that of the 8 petal design. However, no clear effect changing
the central diameter was observed.
Microvesicle transport and detection in the concentrator
device
Next, the concentrator devices were used to concentrate microtubules that capture
and transport microvesicles from a cell-line derived sample. Microvesicles are
membrane bound sacs shed from almost all cell types, and are important biomark-
ers for disease diagnosis. Here, purified microvesicles from leukemia cell line were
used to demonstrate proof-of-principle application of using microtubule-kinesin
system in an on-chip detection system.
Anti-CD45 monoclonal antibody-conjugated microtubules (Ab-MTs) were pre-
pared as described earlier (see Chapter 2). Human T-cell leukemia cell line DND41
and human osteosarcoma cell line MG63 were used to purify leukemic CD45+
and control CD45- microvesicles respectively. The cell lines were labeled with
fluorescent dye prior to microvesicle isolation, yielding fluorescent microvesicles.
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Figure 4.7: Microvesicle transport in the concentrator device. - Fluores-
cence images of the antibody-conjugated microtubules before (left) and after (right,
red microtubules) the addition of the leukemia microvesicles
The fluorescent microvesicles were added in motility solution to the concentrator
devices. As observed in Chapter 2, the gliding Ab-MTs can selectively capture
and transport the CD45+ leukemia microvesicles. Additionally, the leukemia
microvesicles with multiple CD45 sites on their surface cross-linked the gliding
Ab-MTs, causing the latter to bundle into larger supramolecular assemblies.
Unlike the single microtubule filaments, these large Ab-MT bundles, with their
impaired motility and much larger dimensions, could no longer be “guided” by the
concentrator device to move to the central disc. As a consequence of this Ab-MT
bundling, the application of the concentrator devices towards the development of
an on-chip microvesicle detection system proved unsuccessful.
4.3 Conclusion
Lithographically patterned nanostructures have emerged as a promising approach
to control directionality of microtubule motility in vitro. Here, the effect of fun-
damental constituents – the assay setup, kinesin motor from different expression
systems, microtubule preparation methods – on the efficiency of guiding microtu-
bule motility in the nanostructures was investigated. An optimized assay protocol
was established based on the evaluated parameters, with improved motility and
robust guidance of gliding microtubules in the nanostructures. These develop-
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ments would allow exploration of more challenging nanotechnological applications
based on the biomolecular motor system.
Specific design of the nanostructures was then used to develop spatial guidance
aided spatio-temporal concentration of microtubules. The concentrator devices
achieved almost two-fold increase in microtubule concentration in some designs
within a 5 min timeframe. While the concentration factor was not as remarkable as
those reported by some earlier designs9, there is potential to improve the current
design to enhance the device performance – for example by capping the central
collector region to arrest escaping microtubule following saturation of binding sites,
or using a spiral rectifier at the center instead of one uniform circular patch to
enable the concentrated microtubule to access the entire region (instead of being
restricted in the peripheral ring, in our current example). Nevertheless, with the
optimized assay protocol in place, development of next generation concentrator
devices with improved performance is feasible.
While the proof-of-principle application of using microtubule transport in
concentrator device to detect medically-relevant microvesicles was thwarted by
the bundling of microtubules due to the analyte, several examples of highly
sensitive analyte detection with antibody-conjugated microtubules on glass surface
suggests that the system could be adapted for concentrator devices, particularly
for the detection of monovalent analyte. Optimized device design9,74, enhanced
fluorescence detection130, and magnetic pre-separation of analyte131 for improved
sensitivity are some other strategies in the direction of development of practical
diagnostic application with biomolecular motors systems.
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Summary and outlook
This thesis describes experimental work at the interface of biology, chemistry,
and nanotechnology to addresses some of the current challenges in the develop-
ment of nanotechnological applications using biomolecular motors. Microtubules
and kinesin motor proteins were used in vitro to reconstitute the highly efficient
biomolecular transport. These biological components were then chemically mod-
ified to impart functionalities, such as, synthetic cargo transport capability, in
order to develop nanotechnological applications.
A robust conjugation scheme to covalently conjugate microtubules was de-
veloped using the recently described bioorthogonal, iEDDA reaction between
tetrazine and trans-cyclooctene. This latest class of “click chemistry” reaction
was successfully applied to load a variety of cargo to the microtubules, such as,
fluorescent dye, antibodies, and streptavidin.
The effect of flexible PEG linker length on the cargo attachment to microtubules
was investigated using the developed conjugation scheme. Increase in the linker
length was found to enhance the cargo loading to the microtubules. Moreover,
attachment of cargo to microtubules via linker longer than the dimension of
kinesin motor head was found to rescue the decreased transport velocity reported
earlier on loading cargo to microtubules.
The microtubules with covalently conjugated antibodies were used in gliding
motility assays to engineer biosensing applications. Highly selective, fluorescence-
based detection of protein analyte was achieved using a TIRF microscope setup.
Label-free detection of microvesicles and proteins was engineered using the
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supramolecular self-assembly of antibody-conjugated-microtubules gliding over
the kinesin surface. This label-free detection method was also employed to profile
cross-reactivity between commercially available secondary antibodies.
Finally, lithographically patterned nanostructures were used to successfully
guide microtubules in a gliding motility assay and achieve spatio-temporal con-
centration of the gliding microtubules (with/without cargo). The basic assay
parameters were optimized to obtain efficient guiding of the gliding microtubules
in these nanostructures.
5.1 Outlook
Versatile cargo conjugation The covalent cargo conjugation scheme devel-
oped in Chapter 2 is a promising alternative to the non-covalent streptavidin-biotin
conjugation traditionally used in the field. The straightforwardness of the protocol
developed, coupled with the recent commercial availability of the reagents with
different functionalities, makes this scheme promising for the conjugation of a
variety of cargo to microtubules in vitro. Additionally, the iEDDA chemistry is
orthogonal to other “click reactions”, opening up possibilities for the simultaneous
and/or sequential assembly of multiple modular units to microtubules.
Analyte detection The biosensing applications developed - fluorescence-based
as well as the label-free analyte detection schemes - are both based on molecular
recognition by antibodies. As antibodies are gold standard affinity probes, the de-
tection methods reported in this thesis are pertinent proof-of-principle applications
that can be extended to the detection of a wide range of analytes. A direct future
application would entail employing gliding microtubules as a surface for ELISA-
type of detection assay. Such an assay, where analyte is detected by antibodies
covalently conjugated to gliding microtubules, would retain the advantages of the
traditional ELISA assays, while conferring the additional distinction of specifically
transported analyte from non-specific stationary molecules that bind to the surface
of the assay chamber. The basis for such an assay has already been developed
in this thesis, and proof-of-principle applications have been demonstrated with
model protein analytes and cell-derived protein samples. Moreover, the example
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of abl-bcr fusion protein detection shows that gliding microtubules can also act
as a substrate to pull-down specific biomolecules with affinity for α or β tubulin,
or detect the presence of microtubule-associated proteins (MAPs) from a sample.
As microtubule-kinesin transport has been shown to be compatible to a wide
variety of sample solutions101, further development of novel detection assays for
point-of-care diagnosis will be a promising area to explore.
Motor-roadblock studies In vivo, the motor proteins transport their cargo
along the microtubules while successfully navigating through the highly crowded
cellular environment. As breakdown of this transport machinery is related to
several pathological conditions, it is crucial to understand how the motor proteins
circumvent obstacles encountered during transport. In vitro, the purified motor
proteins function optimally in different buffer systems, making it challenging to
compare the behaviour of different motor proteins to factors such as the amount
of roadblocks present on the microtubule surface. The covalent conjugation of
roadblocks to microtubules, developed in Chapter 2, overcomes this challenge by
providing a setting to compare how different motor proteins navigate obstacles in
vitro. Characterization of different motor proteins (in their respective buffer sys-
tems) stepping on microtubules with covalently conjugated permanent roadblocks
will help us understand how different motor proteins navigate around obstacles
and what are the different strategies employed to do so.
Assay on nanostructures To generate controlled motion of gliding micro-
tubules, spatial rectification of microtubule motion in lithographically patterned
nanostructures have been most successful till date. An important gap in the
practical translation of these chip-based assays was addressed in this thesis by
investigating how the basic components of the assay influence the microtubule
guiding efficiency in the chips. This led to the establishment of optimized parame-
ters for achieving successful control of microtubule motility in nanotechnological
applications. Finally, further work can integrate the bioconjugation scheme and
the detection principles of the biosensing assays for controlled motility on the
nanostructures towards the development of real-world point-of-care diagnostics
applications.
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Materials and methods
6.1 Reagents
Anti-Abl antibody Antibodies-online, Catalog no.: ABIN885839
Anti-Bcr antibody, AlexaFluor488 Antibodies-online, Catalog no.: ABIN879125
Anti-goat antibody Thermo Fisher Scientific, Catalog no.: A-21081
Anti-hAbl antibody R & D Systems, Catalog no.: AF5414
Anti-hBcr antibody R & D Systems, Catalog no.: AF5129
Anti-hCD45 antibody R & D Systems, Catalog no.: MAB1430
Anti-mouse antibody, Alexa Fluor 488 conjugate Thermo Fisher Scientific,
Catalog no.: A-11001
ATP Roche Diagnostics GmbH, Catalog no.: 1051998700
Catalase Sigma, Catalog no.: C40
CellTracker™ Deep Red Dye Thermo Fisher Scientific, Catalog no.: C34565
CellTracker™ Green CMFDA Dye Thermo Fisher Scientific, Catalog no.:
C7025
Coverslips Menzel Gläser
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DMSO Sigma, Catalog no.: 276855
DTT Fermentas, Catalog no.: R0862
EDTA VWR, Catalog no.: 443885J
EGTA Sigma, Catalog no.: E4378
Glucose Oxidase SERVA, Catalog no.: 22778
GMPCPP Jena Bioscience, Catalog no.: NU-405L
GTP Roche Diagnostics GmbH, Catalog no.: 10106399
KOH Merck, Catalog no.: 1.05012.1000
Methanol VWR, Catalog no.: 1.06009.2500
Methyl-Tetrazine-ATTO-488 Jena Bioscience, Catalog no.: CLK-021-02
Methyl-Tetrazine-PEG5-NHS Jena Bioscience, Catalog no.: CLK-A138-10
Parafilm Bemis Company
PIPES Sigma Aldrich, Catalog no.: 80635-250g
Streptavidin, AlexaFluor488 Thermo Fisher Scientific, Catalog no.: S11223
Streptavidin, AlexaFluor546 Thermo Fisher Scientific, Catalog no.: S11225
Taxol Sigma, Catalog no.: T7191
TCO-NHS Jena Bioscience, Catalog no.: CLK-1016-25
TCO-PEG4-NHS Jena Bioscience, Catalog no.: CLK-A137-10
TCO-PEG12-NHS Iris Biotech, Catalog no.: TCO1020.0010
72
6.2 Buffers
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BRB80 80 mM PIPES/KOH, pH 6.9; 1 mM EGTA, 1 mM MgCl2.
BRB80T 10 µM taxol containing BRB80 solution.
High pH cushion: 0.1 M HEPES/NaOH, pH 8.6, 1 mM MgCl2, 1 mM EGTA,
60 % (v/v) glycerol.
Labeling buffer: 0.1 M HEPES/NaOH, pH 8.6, 1 mM MgCl2, 1 mM EGTA,
40 % (v/v) glycerol.
Stop solution: 2x BRB80 with 100 mM K-Glutamate and 40 % (v/v) glycerol.
Low pH cushion BRB80 supplemented with 60 % (v/v) glycerol.
Motility solution 1 mM ATP, 20 mM D-glucose, 20 µg/ml glucose oxidase,
10 µg/ml catalase, 0.5 % β-mercapto-ethanol, 10 µM taxol in BRB80.
Piranha solution 175 ml H2SO4 (70 %) + 75 ml H2O2 (30 %). Mixed by slowly
adding H2O2 to H2SO4. (Note: solution highly corrosive! Handle with care
in fume hood only.)
6.3 Kinesin-1 and microtubules
Full length Kinesin-1 was purified using an insect cell expression system by Till
Korten and Marcus Braun with help from the Protein Expression facilty at the
MPI-CBG (protocol published125). Tubulin was purified from pig brain following
established protocol132. Corina Bräuer conducted the tubulin purification, with
help from all the members of the Diez lab.
Functionalization of microtubules
Microtubules were functionalized as described by Hyman et al. 133 .
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Figure 6.1: Microtubule functional-
ization. - (1, 2) Polymerized micro-
tubules were functionalized with X-NHS es-
ter reagent. (3, 4) The functionalized micro-
tubules were subjected to a cycle of depoly-
merization and re-polymerization to sepa-
rate the functional tubulin from the non-
functional tubulin (gray). (5) The micro-
tubules are depolymerized to obtain func-
tionalized tubulin.
Tubulin at high concentration
(usually 4.5 ml of 13 mg/ml tubu-
lin) was mixed with 0.5X BRB80,
1 mM GTP, 3.5 mM MgCl2 and 33%
glycerol, and incubated on ice for 5
min. Thereafter, microtubules were
polymerized by transferring the mix-
ture to a 37˚C water bath and in-
cubating for 1 h. The polymerized
microtubules were spun through a
high pH cushion in a pre-warmed
MLA80 rotor at 50 000 rpm for
45 min. The pellet obtained was
carefully rinsed twice with warm
BRB80 at 37˚C, and then resus-
pended in 37˚C warm labeling buffer.
The N-Hydroxysuccinimide (NHS)-
functionalized reagent was dissolved
in dimethyl sulfoxide (DMSO), added
to the labeling buffer solution and in-
cubated for 30 min at 37˚C to label
the solvent accessible amino groups
on the microtubules. To end the la-
beling reaction, two reaction volumes
of stop solution was added to the mix-
ture and incubated for 5 min. The
labeled microtubules were then lay-
ered onto a low pH cushion and cen-
trifuged in a pre-warmed MLA80 ro-
tor at 50 000 rpm for 60 min at 37˚C.
The pellet obtained was rinsed thrice
with BRB80 solution pre-warmed at
37˚C and then resuspended in 1 ml
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ice cold injection buffer. The solution was transferred to a 2 ml douncer (cooled
on ice), and occasionally dounced while incubating on ice for at least 40 min,
to obtain a clear homogeneous solution of depolymerized microtubules. These
depolymerized microtubules were centrifuged in a precooled MLA130 rotor at 60
000 rpm for 30 min at 4˚C. The supernatant was recovered and supplemented
with 5X BRB80, GTP and MgCl2 to a final concentration of 1X, 1 mM and 4 mM
respectively. This mixture was incubated on ice for 3 min, then in a 37˚C water
bath for 2 min. Glycerol was added corresponding to 33% of the final total mixture
volume. The solution was then vortexed and incubated at 37˚C for 30 min to
polymerize microtubules from the labeled tubulin. The polymerized microtubules
were then layered onto a prewarmed low pH cushion and centrifuged at 50 000
rpm in a pre-warmed MLA80 rotor for 30 min at 37˚C. The pellet was rinsed
twice with warm BRB80 and resuspended in ice cold BRB80. The resuspended
pellet solution was incubated on ice for about 30 min to depolymerize the micro-
tubules. The depolymerized microtubules were then centrifuged in a pre-cooled
MLA130 rotor at 60000 rpm for 10 min at 4˚C. The supernatant comprising
labeled tubulin was recovered. The concentration of tubulin was estimated by
measuring the absorption at 280 nm (extinction coefficient of tubulin dimers is
115000 M−1cm−1). The labeled tubulin was then aliquoted at 4 mg/ml and stored
at -80˚C (or liquid nitrogen for long-term storage).
Preparation of microtubules
Microtubules were prepared using the following three methods:
Taxol-stabilized microtubules (Tx-MTs) To prepare Tx-MTs, a polymer-
ization pre-mix solution was prepared with 1.8 µl BRB80, 1.2 µl DMSO, 1 µl
100 mM MgCl2, 1 µl 25 mM GTP. 1.25 µl of this solution was added to 5 µl
of 4 mg/ml tubulin and incubated at 37˚C. After 30-60 min, the polymerized
microtubules were stabilized and diluted 100-fold in BRB80T solution.
GMP-CPP stabilized microtubules (CPP-MTs) To prepare CPP-MTs,
64 µl BRB80, 1 µl 100 mM MgCl2 and 10 µl 10 mM GMPCPP were added to
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5 µl of 4 mg/ml tubulin solution and incubated at 37˚C overnight. Thereafter,
the BRB80 was added and the microtubule solution centrifuged at 17 000 g in an
airfuge for 5 min. The supernatant was discarded and the pellet was resuspended
in BRB80.
Double-stabilized microtubules (dsMTs) To prepare ds-MTs, 64 µl BRB80,
1 µl 100 mM MgCl2 and 10 µl 10 mM GMPCPP were added to 5 µl of 4 mg/ml
tubulin solution and incubated at 37˚C. After 90-120 min, 120 µl of BRB80T was
added and the microtubule solution centrifuged at 17 000 g in an airfuge for 5 min.
The supernatant was discarded and the pellet was resuspended in BRB80T.
6.4 Cell culture and microvesicle (MV) purifica-
tion
Human T cell leukemic cell line DND41 and human osteosarcoma cell line MG63
were cultured in RPMI 1640 media and DMEM media respectively (media pur-
chased from GIBCO and supplemented with 10% fetal bovine serum, 2 mM
L-Glutamine, 100 U/ml penicillin and 10 U/ml streptomycin), and incubated
at 37˚C and 5% CO2. To isolate MVs, 50 ml of the culture medium from
1000 cells/µl was centrifuged at 250 g for 5 min. The supernatent was taken out
and centrifuged at 2500 g for 15 min at 4°C. The cell-free supernatent obtained
from this step was centrifuged at 18000 g for 2 hours at 4°C to obtain the MVs.
The pellet obtained was resuspended in PBS. To obtain fluorescently-labeled MVs,
the DND41 and MG63 cell lines were stained with CellTracker™ Green CMFDA
Dye and CellTracker™ Deep Red Dye respectively. 5 µM of the dye was added to
the cells in PBS, incubated at 37°C and 5% CO2 for 30 min, followed by removal
of the dye-containing PBS media, and resuspension of the cells in their respective
culture media. These fluorescently-labeled cells shed fluorescent MVs, which were
similarly isolated.
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A combination of nanofabrication process and chemical adsorption, similar to the
one described earlier123, was used to design the chips. The chips were designed
and fabricated through collaboration between Till Korten and members of the
Bartha group at TU Dresden.
Briefly, the fabrication process involved sputter deposition of a 100 nm Au
layer on a 105 mm silicon (Si) wafer, with two 10 nm-thick Ti adhesion systems
sandwiched in between. This was followed by deposition of a 500 nm-thick quartz
layer and a resist layer. The resist was developed (with a specific design of mask)
after exposure in an optical lithography system. Thereafter, the quartz layer was
dry-etched down to the Au layer to complete the nanofabrication process. The
chips thus obtained were cleaned in acetone, followed by rinsing with ethanol and
nanopure water. To block motility on the channel sidewalls, a protein-repellant
coating of poly-ethylene glycol (PEG) self-assembled monolayer (SAM) was then
undertaken.
6.6 Assay setup
Preparation and cleaning of cover slips and chips
The glass coverslips were prepared by Corina Bräuer or Valeria Candia Campano.
Easy cleaning of glass coverslips The glass coverslips were placed in teflon
holder and soaked in glass container comprising 1:20 dilution of Mucasol. The
solution was sonicated for 15 min followed by rinsing the coverslips with a stream
of deionized water for 2 min. The glass container with the coverslips was then
filled with ethanol. After sonicating for 15 min, the coverslips were rinsed with
nanopure water (Milli-Q, Millipore Cooperation, USA), the teflon rack with the
coverslips taken out and carefully blown dry with N2.
Piranha cleaning of glass coverslips and Si chips Samples were put in
teflon holder and put in beaker and sonicated for 5 min in ethanol:water (1:1)
solution. Thereafter, the samples were rinsed in a stream of deionized water for
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2 min. The samples were then soaked in piranha solution kept on hot plate at
60°C for 30-40 min for the glass samples, and 30 s for the Si chips. The samples
were then rinsed thrice with nanopure water, taken out from the teflon racks and
carefully blown dry with N2.
PEGylation of glass coverslips and Si chips 50 ml of toluene was measured
out in a beaker and 115 mg of PEG-silane added. After stirring the solution to
ensure proper mixing of the silane, 40 µl of concentrated HCl was added. The
cleaned glass coverslips or the Si chips were placed in a teflon holder and placed in
this solution for 18 hours with stirring (with the beaker covered). Thereafter the
samples are cleaned by rinsing in toluene (once), ethanol (twice), and nanopure
water (twice). The teflon rack with the samples taken out and carefully blown
dry with N2.
Assembly of flow cells
Flow cells were assembled from two cover slips (Corning, 22x22 mm2 and 18x18
mm2) by placing thin parafilm stripes parallely in between. The channels thus
formed were sealed laterally by melting the parafilm by heating the glass cover
slips to approximately 60 - 70°C.
The larger glass coverslips were cleaned by easy-clean procedure while the upper
smaller glass coverslip used were PEGylated glass cover slips. For the experiments
with the chips, flow cells were assembled by sandwiching the structured Si chip
with a PEGylated glass cover slip with stretched parafilm in between.
Gliding assays
Gliding motility assays were performed in the assembled flow cells using standard
protocol93. A 0.5 mg/ml solution of casein in BRB80 was flowed in and incubated
for 2 min. Kinesin-1 solution (12.5 nM) was then added and incubated for 2 min.
Finally, a motility solution (1 mM ATP, 20 mM D-glucose, 20 mM glucose oxidase,
10 mM catalase, 10 mM DTT, and 10 µM taxol in BRB80) with the microtubules
was added. Excess unbound microtubules were removed by flushing motility
solution without the microtubules.
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6.7 Image acquisition and data analysis
Gliding assay on glass surface
Fluorescence images were acquired with a Nikon Eclipse Ti microscope (with
Perfect Focus System) and a PlanApo 100x (NA 1.49) oil immersion objective
lens. For epi-fluorescence imaging, a metal arc lamp (Intensilight, Nikon) was
used for excitation along with the appropriate filter sets for rhodamine dye
(ex:555/25.Dichroic 561 LP, em: 609/54), Cy5 (ex: 642/20, Dichroic 647 LP, em:
700/75), and Alexa Fluor 488 dye (ex: 475/35, Dichroic 491 LP, em: 525/45).
Timelapse images were recorded with a 100 ms exposure time using an electron-
multiplying charge-coupled device camera (Andor iXon ultra EMCCD, DU-897U)
with NIS-Elements imaging software.
Gliding assays on Si chips
Fluorescence images were acquired using a Zeiss Axiovert 200M inverted optical mi-
croscope with a Plan-Apochromat 40x (NA 0.95) air objective. For epi-fluorescence
imaging, a metal arc lamp was used for excitation along with the appropriate
filter sets for rhodamine dye (ex:535/50, Dichroic 565 LP, em: 610/75), Cy5 (ex:
640/20. Dichroic 660 LP, em: 680/30), and Alexa Fluor 488 dye (ex: 480/40,
Dichroic 505 LP, em: 535/50). Timelapse images were recorded with a 100 ms
exposure time using an electron-multiplying charge-coupled device camera (Andor
iXon ultra EMCCD, DU-897U) with Metamorph imaging software.
Data analysis
All the results presented are from experiments repeated at least three times (except
data for section 4.2).
Data analysis was performed using Fiji, MATLAB, FIESTA134, and GraphPad
Prism softwares. Microtubule gliding velocity was evaluated using FIESTA - an
in-house MATLAB-based tracking software. The amount of fluorescent cargo (dye,
antibodies) on the microtubules was quantified as follows: The integrated intensity
in the corresponding fluorescent channel was measured using the microtubules
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as the mask. The same mask was used to read out the background from an
adjacent empty area, which was then subtracted from the original signal to obtain
background-subtracted fluorescence intensities. In Chapter 4, the approach angle
of the microtubules was measured by hand in Fiji.
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A. Månsson, S. Diez, H. Linke, and D. V. Nicolau. 2016. Parallel computation with
molecular-motor-propelled agents in nanofabricated networks. Proceedings of the National
Academy of Sciences of the United States of America, 113(10):2591–6. 51
[125] T. Korten, S. Chaudhuri, E. Tavkin, M. Braun, and S. Diez. 2016. Kinesin-1 Expressed
in Insect Cells Improves Microtubule in Vitro Gliding Performance, Long-Term Stability
and Guiding Efficiency in Nanostructures. IEEE Transactions on NanoBioscience, 15(1):
62–69. 56, 73
[126] T. Hawkins, M. Mirigian, M. Selcuk Yasar, and J. L. Ross. 2010. Mechanics of microtubules.
Journal of Biomechanics, 43(1):23–30. 58
[127] B. Mickey and J. Howard. 1995. Rigidity of microtubules is increased by stabilizing agents.
The Journal of Cell Biology, 130(4). 58
[128] H. Felgner, R. Frank, J. Biernat, E. M. Mandelkow, E. Mandelkow, B. Ludin, A. Matus,
and M. Schliwa. 1997. Domains of neuronal microtubule-associated proteins and flexural
rigidity of microtubules. The Journal of Cell Biology, 138(5):1067–75.
[129] T. L. Hawkins, D. Sept, B. Mogessie, A. Straube, and J. L. Ross. 2013. Mechanical
properties of doubly stabilized microtubule filaments. Biophysical Journal, 104(7):1517–28.
58
[130] D. Axelrod. 2001. Total Internal Reflection Fluorescence Microscopy in Cell Biology.
Traffic, 2(11):764–774. 65
[131] S. Kumar, L. Ten Siethoff, M. Persson, N. Albet-Torres, and A. Månsson. 2013. Magnetic
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